Gene.Name	Census.Gene	Drug.Name	Mutation	Orig_AA	Position_AA	Mut_AA	Gen.Mutation	Gen_mutated_from	Gen_mutated_to	Primary.Tissue	Histology	Histology.Subtype.1	Histology.Subtype.2	Zygosity	Transcript_info	cosmic_posn	uniprot_id	uniprot_posn	comes_from
KIT	Yes	Imatinib	T670I	T	670	I	2009C>T	C	T	soft_tissue	gastrointestinal_stromal_tumour	spindle	NS	Homozygous	ENST00000288135.5	670	P10721	670	cosmicV97nov2022
EGFR_ENST00000454757	No	Gefitinib	T745M	T	745	M	2234C>T	C	T	lung	carcinoma	adenocarcinoma	NS	Unknown	ENST00000454757.6	745	P00533	790	cosmicV97nov2022
EGFR	Yes	Gefitinib	T790M	T	790	M	?	?	NA	lung	carcinoma	squamous_cell_carcinoma	NS	Unknown	ENST00000275493.6	790	P00533	790	cosmicV97nov2022
EGFR	Yes	Gefitinib	T790M	T	790	M	?	?	NA	lung	carcinoma	adenocarcinoma	NS	Unknown	ENST00000275493.6	790	P00533	790	cosmicV97nov2022
KIT	Yes	Imatinib	V654A	V	654	A	?	?	NA	soft_tissue	gastrointestinal_stromal_tumour	NS	NS	Unknown	ENST00000288135.5	654	P10721	654	cosmicV97nov2022
ABL1_ENST00000318560	No	Imatinib	T315I	T	315	I	?	?	NA	haematopoietic_and_lymphoid_tissue	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	Unknown	ENST00000318560.5	315	P00519	315	cosmicV97nov2022
ABL1_ENST00000318560	No	Imatinib	G250E	G	250	E	?	?	NA	haematopoietic_and_lymphoid_tissue	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	Unknown	ENST00000318560.5	250	P00519	250	cosmicV97nov2022
ABL1_ENST00000318560	No	Imatinib	Y253H	Y	253	H	?	?	NA	haematopoietic_and_lymphoid_tissue	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	Unknown	ENST00000318560.5	253	P00519	253	cosmicV97nov2022
EGFR	Yes	Tyrosine kinase inhibitor - NS	T790M	T	790	M	?	?	NA	lung	carcinoma	adenocarcinoma	NS	Unknown	ENST00000275493.6	790	P00533	790	cosmicV97nov2022
EGFR_ENST00000454757	No	Gefitinib	T745M	T	745	M	2234C>T	C	T	lung	carcinoma	adenocarcinoma	NS	Heterozygous	ENST00000454757.6	745	P00533	790	cosmicV97nov2022
ABL1_ENST00000318560	No	Tyrosine kinase inhibitor - NS	T315I	T	315	I	?	?	NA	haematopoietic_and_lymphoid_tissue	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	Unknown	ENST00000318560.5	315	P00519	315	cosmicV97nov2022
ABL1_ENST00000318560	No	Tyrosine kinase inhibitor - NS	E255K	E	255	K	?	?	NA	haematopoietic_and_lymphoid_tissue	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	Unknown	ENST00000318560.5	255	P00519	255	cosmicV97nov2022
ALK_ENST00000642122	No	Crizotinib	L128M	L	128	M	382C>A	C	A	lung	carcinoma	adenocarcinoma	NS	Homozygous	ENST00000642122.1	128	Q9UM73	1196	cosmicV97nov2022
PDGFRA	Yes	Imatinib	D842V	D	842	V	?	?	NA	soft_tissue	gastrointestinal_stromal_tumour	NS	NS	Unknown	ENST00000257290.9	842	P16234	842	cosmicV97nov2022
EGFR	Yes	Gefitinib	T790M	T	790	M	2369C>T	C	T	lung	carcinoma	non_small_cell_carcinoma	NS	Unknown	ENST00000275493.6	790	P00533	790	cosmicV97nov2022
KIT	Yes	Imatinib	T670I	T	670	I	?	?	NA	soft_tissue	gastrointestinal_stromal_tumour	NS	NS	Unknown	ENST00000288135.5	670	P10721	670	cosmicV97nov2022
ABL1_ENST00000318560	No	Dasatinib	T315I	T	315	I	?	?	NA	haematopoietic_and_lymphoid_tissue	lymphoid_neoplasm	acute_lymphoblastic_leukaemia	Ph_positive	Unknown	ENST00000318560.5	315	P00519	315	cosmicV97nov2022
KIT	Yes	Imatinib	N822K	N	822	K	?	?	NA	soft_tissue	gastrointestinal_stromal_tumour	spindle	NS	Unknown	ENST00000288135.5	822	P10721	822	cosmicV97nov2022
KIT	Yes	Imatinib	V654A	V	654	A	1961T>C	T	C	soft_tissue	gastrointestinal_stromal_tumour	spindle	NS	Unknown	ENST00000288135.5	654	P10721	654	cosmicV97nov2022
EGFR	Yes	Erlotinib	T790M	T	790	M	?	?	NA	lung	carcinoma	adenocarcinoma	NS	Unknown	ENST00000275493.6	790	P00533	790	cosmicV97nov2022
EGFR	Yes	Tyrosine kinase inhibitor - NS	T790M	T	790	M	?	?	NA	lung	carcinoma	non_small_cell_carcinoma	NS	Unknown	ENST00000275493.6	790	P00533	790	cosmicV97nov2022
BTK_ENST00000618050	No	Acalabrutinib	C481S	C	481	S	1442G>C	G	C	haematopoietic_and_lymphoid_tissue	lymphoid_neoplasm	chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma	NS	Unknown	ENST00000618050.4	481	Q06187	481	cosmicV97nov2022
BTK_ENST00000618050	No	Ibrutinib	C481S	C	481	S	1442G>C	G	C	haematopoietic_and_lymphoid_tissue	lymphoid_neoplasm	chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma	NS	Unknown	ENST00000618050.4	481	Q06187	481	cosmicV97nov2022
EGFR	Yes	Osimertinib	L718Q	L	718	Q	2153T>A	T	A	lung	carcinoma	adenocarcinoma	NS	Unknown	ENST00000275493.6	718	P00533	718	cosmicV97nov2022
EGFR	Yes	Afatinib	C797S	C	797	S	?	?	NA	lung	carcinoma	adenocarcinoma	NS	Unknown	ENST00000275493.6	797	P00533	797	cosmicV97nov2022
FGFR2_ENST00000613048	No	Palbociclib	N460K	N	460	K	1380T>A	T	A	breast	carcinoma	ER-positive_carcinoma	NS	Unknown	ENST00000613048.4	460	P21802	549	cosmicV97nov2022
FGFR2_ENST00000369059	No	BGJ398	L503M	L	503	M	1507T>A	T	A	biliary_tract	carcinoma	adenocarcinoma	NS	Unknown	ENST00000369059.5	503	P21802	617	cosmicV97nov2022
ABL1_ENST00000318560	No	Imatinib	T315I	T	315	I	?	?	NA	haematopoietic_and_lymphoid_tissue	haematopoietic_neoplasm	blast_phase_chronic_myeloid_leukaemia	NS	Unknown	ENST00000318560.5	315	P00519	315	cosmicV97nov2022
ABL1_ENST00000318560	No	Imatinib	E255K	E	255	K	?	?	NA	haematopoietic_and_lymphoid_tissue	haematopoietic_neoplasm	blast_phase_chronic_myeloid_leukaemia	NS	Unknown	ENST00000318560.5	255	P00519	255	cosmicV97nov2022
ALK	Yes	Ceritinib	G1202R	G	1202	R	?	?	NA	lung	carcinoma	non_small_cell_carcinoma	NS	Unknown	ENST00000389048.7	1202	Q9UM73	1202	cosmicV97nov2022
KIT	Yes	Imatinib	D816H	D	816	H	?	?	NA	soft_tissue	gastrointestinal_stromal_tumour	NS	NS	Unknown	ENST00000288135.5	816	P10721	816	cosmicV97nov2022
KIT	Yes	Imatinib	D820Y	D	820	Y	?	?	NA	soft_tissue	gastrointestinal_stromal_tumour	NS	NS	Unknown	ENST00000288135.5	820	P10721	820	cosmicV97nov2022
ABL1_ENST00000318560	No	Imatinib	F317L	F	317	L	?	?	NA	haematopoietic_and_lymphoid_tissue	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	Unknown	ENST00000318560.5	317	P00519	317	cosmicV97nov2022
ABL1_ENST00000318560	No	Imatinib	E255K	E	255	K	?	?	NA	haematopoietic_and_lymphoid_tissue	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	Unknown	ENST00000318560.5	255	P00519	255	cosmicV97nov2022
EGFR_ENST00000455089	No	Gefitinib	T745M	T	745	M	2234C>T	C	T	lung	carcinoma	adenocarcinoma	NS	Heterozygous	ENST00000455089.5	745	P00533	790	cosmicV97nov2022
ABL1	Yes	Imatinib	T334I	T	334	I	1001C>T	C	T	haematopoietic_and_lymphoid_tissue	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	Unknown	ENST00000372348.6	334	P00519	315	cosmicV97nov2022
ABL1_ENST00000318560	No	Imatinib	T315I	T	315	I	?	?	NA	haematopoietic_and_lymphoid_tissue	haematopoietic_neoplasm	chronic_myeloid_leukaemia	Ph_positive	Unknown	ENST00000318560.5	315	P00519	315	cosmicV97nov2022
ABL1_ENST00000318560	No	Imatinib	E255K	E	255	K	?	?	NA	haematopoietic_and_lymphoid_tissue	haematopoietic_neoplasm	chronic_myeloid_leukaemia	Ph_positive	Unknown	ENST00000318560.5	255	P00519	255	cosmicV97nov2022
EGFR	Yes	Osimertinib	C797S	C	797	S	?	?	NA	lung	carcinoma	non_small_cell_carcinoma	NS	Unknown	ENST00000275493.6	797	P00533	797	cosmicV97nov2022
BTK_ENST00000618050	No	Ibrutinib	C481S	C	481	S	1441T>A	T	A	haematopoietic_and_lymphoid_tissue	lymphoid_neoplasm	chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma	NS	Homozygous	ENST00000618050.4	481	Q06187	481	cosmicV97nov2022
FGFR2_ENST00000358487	No	BGJ398	V564F	V	564	F	?	?	NA	biliary_tract	carcinoma	adenocarcinoma	NS	Unknown	ENST00000358487.9	564	P21802	564	cosmicV97nov2022
ABL1_ENST00000318560	No	Dasatinib	T315I	T	315	I	?	?	NA	haematopoietic_and_lymphoid_tissue	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	Unknown	ENST00000318560.5	315	P00519	315	cosmicV97nov2022
ALK	Yes	Crizotinib	G1202R	G	1202	R	?	?	NA	lung	carcinoma	non_small_cell_carcinoma	NS	Unknown	ENST00000389048.7	1202	Q9UM73	1202	cosmicV97nov2022
BTK_ENST00000308731	No	Ibrutinib	C481Y	C	481	Y	1442G>A	G	A	haematopoietic_and_lymphoid_tissue	lymphoid_neoplasm	chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma	NS	Unknown	ENST00000308731.7	481	Q06187	481	cosmicV97nov2022
FGFR1_ENST00000335922	No	Palbociclib	N536K	N	536	K	1608C>A	C	A	breast	carcinoma	ER-positive_carcinoma	NS	Unknown	ENST00000335922.9	536	P11362	546	cosmicV97nov2022
FGFR2_ENST00000356226	No	BGJ398	L500M	L	500	M	1498T>A	T	A	biliary_tract	carcinoma	adenocarcinoma	NS	Unknown	ENST00000356226.8	500	P21802	617	cosmicV97nov2022
KIT	Yes	Imatinib	N822K	N	822	K	?	?	NA	soft_tissue	gastrointestinal_stromal_tumour	NS	NS	Unknown	ENST00000288135.5	822	P10721	822	cosmicV97nov2022
KIT	Yes	Imatinib	N822Y	N	822	Y	?	?	NA	soft_tissue	gastrointestinal_stromal_tumour	NS	NS	Unknown	ENST00000288135.5	822	P10721	822	cosmicV97nov2022
ABL1_ENST00000318560	No	Dasatinib	F317L	F	317	L	?	?	NA	haematopoietic_and_lymphoid_tissue	haematopoietic_neoplasm	chronic_myeloid_leukaemia	Ph_positive	Unknown	ENST00000318560.5	317	P00519	317	cosmicV97nov2022
ABL1_ENST00000318560	No	Tyrosine kinase inhibitor - NS	T315I	T	315	I	944C>T	C	T	haematopoietic_and_lymphoid_tissue	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	Unknown	ENST00000318560.5	315	P00519	315	cosmicV97nov2022
ABL1_ENST00000318560	No	Tyrosine kinase inhibitor - NS	F317L	F	317	L	?	?	NA	haematopoietic_and_lymphoid_tissue	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	Unknown	ENST00000318560.5	317	P00519	317	cosmicV97nov2022
ABL1_ENST00000318560	No	Tyrosine kinase inhibitor - NS	Y253H	Y	253	H	?	?	NA	haematopoietic_and_lymphoid_tissue	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	Unknown	ENST00000318560.5	253	P00519	253	cosmicV97nov2022
ALK_ENST00000618119	No	Crizotinib	L819M	L	819	M	2455C>A	C	A	lung	carcinoma	non_small_cell_carcinoma	NS	Unknown	ENST00000618119.4	819	Q9UM73	1196	cosmicV97nov2022
ALK_ENST00000642122	No	Alectinib	I103N	I	103	N	308T>A	T	A	lung	carcinoma	non_small_cell_carcinoma	NS	Heterozygous	ENST00000642122.1	103	Q9UM73	1171	cosmicV97nov2022
ABL1_ENST00000318560	No	Imatinib	G250E	G	250	E	?	?	NA	haematopoietic_and_lymphoid_tissue	haematopoietic_neoplasm	chronic_myeloid_leukaemia	Ph_positive	Unknown	ENST00000318560.5	250	P00519	250	cosmicV97nov2022
ABL1_ENST00000318560	No	Dasatinib	F317L	F	317	L	?	?	NA	haematopoietic_and_lymphoid_tissue	haematopoietic_neoplasm	blast_phase_chronic_myeloid_leukaemia	NS	Unknown	ENST00000318560.5	317	P00519	317	cosmicV97nov2022
MAP2K2_ENST00000394867	No	Dabrafenib	C28S	C	28	S	83G>C	G	C	skin	malignant_melanoma	NS	NS	Heterozygous	ENST00000394867.8	28	P36507	125	cosmicV97nov2022
KIT	Yes	Imatinib	D820G	D	820	G	?	?	NA	soft_tissue	gastrointestinal_stromal_tumour	NS	NS	Unknown	ENST00000288135.5	820	P10721	820	cosmicV97nov2022
BTK_ENST00000308731	No	Ibrutinib	C481S	C	481	S	1442G>C	G	C	haematopoietic_and_lymphoid_tissue	lymphoid_neoplasm	lymphoplasmacytic_lymphoma	NS	Unknown	ENST00000308731.7	481	Q06187	481	cosmicV97nov2022
EGFR	Yes	Osimertinib	G796D	G	796	D	?	?	NA	lung	carcinoma	adenocarcinoma	NS	Unknown	ENST00000275493.6	796	P00533	796	cosmicV97nov2022
EGFR_ENST00000455089	No	Erlotinib	T745M	T	745	M	2234C>T	C	T	lung	carcinoma	adenocarcinoma	NS	Unknown	ENST00000455089.5	745	P00533	790	cosmicV97nov2022
BTK_ENST00000618050	No	Ibrutinib	C481S	C	481	S	1441T>A	T	A	haematopoietic_and_lymphoid_tissue	lymphoid_neoplasm	chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma	NS	Unknown	ENST00000618050.4	481	Q06187	481	cosmicV97nov2022
BTK_ENST00000308731	No	Ibrutinib	C481S	C	481	S	1442G>C	G	C	haematopoietic_and_lymphoid_tissue	lymphoid_neoplasm	chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma	NS	Unknown	ENST00000308731.7	481	Q06187	481	cosmicV97nov2022
EGFR	Yes	Osimertinib	C797S	C	797	S	?	?	NA	lung	carcinoma	adenocarcinoma	NS	Unknown	ENST00000275493.6	797	P00533	797	cosmicV97nov2022
EGFR_ENST00000454757	No	Osimertinib	C752S	C	752	S	2254T>A	T	A	lung	carcinoma	adenocarcinoma	NS	Unknown	ENST00000454757.6	752	P00533	797	cosmicV97nov2022
EGFR_ENST00000455089	No	Osimertinib	L673V	L	673	V	2017C>G	C	G	lung	carcinoma	adenocarcinoma	NS	Unknown	ENST00000455089.5	673	P00533	718	cosmicV97nov2022
FGFR2_ENST00000478859	No	Palbociclib	N321K	N	321	K	963T>A	T	A	breast	carcinoma	ER-positive_carcinoma	NS	Unknown	ENST00000478859.5	321	P21802	549	cosmicV97nov2022
FGFR2_ENST00000346997	No	BGJ398	E563A	E	563	A	1688A>C	A	C	biliary_tract	carcinoma	adenocarcinoma	NS	Unknown	ENST00000346997.6	563	P21802	565	cosmicV97nov2022
FGFR2_ENST00000613048	No	BGJ398	L528M	L	528	M	1582T>A	T	A	biliary_tract	carcinoma	adenocarcinoma	NS	Unknown	ENST00000613048.4	528	P21802	617	cosmicV97nov2022
ABL1_ENST00000318560	No	Imatinib	T315I	T	315	I	944C>T	C	T	haematopoietic_and_lymphoid_tissue	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	Unknown	ENST00000318560.5	315	P00519	315	cosmicV97nov2022
FGFR2_ENST00000357555	No	INCB054828	N460H	N	460	H	1378A>C	A	C	biliary_tract	carcinoma	adenocarcinoma	NS	Unknown	ENST00000357555.9	460	P21802	549	cosmicV97nov2022
ALK	Yes	Alectinib	G1202R	G	1202	R	?	?	NA	lung	carcinoma	non_small_cell_carcinoma	NS	Unknown	ENST00000389048.7	1202	Q9UM73	1202	cosmicV97nov2022
EGFR_ENST00000455089	No	Gefitinib	T745M	T	745	M	2234C>T	C	T	lung	carcinoma	adenocarcinoma	NS	Unknown	ENST00000455089.5	745	P00533	790	cosmicV97nov2022
EGFR	Yes	Gefitinib	T790M	T	790	M	?	?	NA	lung	carcinoma	bronchioloalveolar_adenocarcinoma	NS	Unknown	ENST00000275493.6	790	P00533	790	cosmicV97nov2022
EGFR	Yes	Gefitinib	T790M	T	790	M	?	?	NA	lung	carcinoma	non_small_cell_carcinoma	NS	Unknown	ENST00000275493.6	790	P00533	790	cosmicV97nov2022
EGFR	Yes	XL647	T790M	T	790	M	?	?	NA	lung	carcinoma	adenocarcinoma	NS	Unknown	ENST00000275493.6	790	P00533	790	cosmicV97nov2022
EGFR_ENST00000455089	No	Gefitinib	T745M	T	745	M	2234C>T	C	T	lung	carcinoma	non_small_cell_carcinoma	NS	Unknown	ENST00000455089.5	745	P00533	790	cosmicV97nov2022
ABL1_ENST00000318560	No	Tyrosine kinase inhibitor - NS	G250E	G	250	E	?	?	NA	haematopoietic_and_lymphoid_tissue	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	Unknown	ENST00000318560.5	250	P00519	250	cosmicV97nov2022
FLT3	Yes	Quizartinib	F691L	F	691	L	2073T>G	T	G	haematopoietic_and_lymphoid_tissue	haematopoietic_neoplasm	acute_myeloid_leukaemia	NS	Unknown	ENST00000241453.11	691	P36888	691	cosmicV97nov2022
ALK_ENST00000642122	No	Crizotinib	L128M	L	128	M	382C>A	C	A	lung	carcinoma	non_small_cell_carcinoma	NS	Unknown	ENST00000642122.1	128	Q9UM73	1196	cosmicV97nov2022
FLT3	Yes	Sorafenib	D835H	D	835	H	2503G>C	G	C	haematopoietic_and_lymphoid_tissue	haematopoietic_neoplasm	acute_myeloid_leukaemia	NS	Heterozygous	ENST00000241453.11	835	P36888	835	cosmicV97nov2022
MET_ENST00000397752	No	Capmatinib	Y1230H	Y	1230	H	3688T>C	T	C	lung	carcinoma	adenocarcinoma	NS	Unknown	ENST00000397752.7	1230	P08581	1230	cosmicV97nov2022
BTK	Yes	Ibrutinib	C515S	C	515	S	1543T>A	T	A	haematopoietic_and_lymphoid_tissue	lymphoid_neoplasm	chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma	Richter_transformation	Unknown	ENST00000621635.4	515	Q06187	481	cosmicV97nov2022
EGFR_ENST00000454757	No	Osimertinib	L673Q	L	673	Q	2018T>A	T	A	lung	carcinoma	adenocarcinoma	NS	Unknown	ENST00000454757.6	673	P00533	718	cosmicV97nov2022
EGFR_ENST00000454757	No	Osimertinib	G674A	G	674	A	2021G>C	G	C	lung	carcinoma	adenocarcinoma	NS	Unknown	ENST00000454757.6	674	P00533	719	cosmicV97nov2022
FGFR2_ENST00000369060	No	BGJ398	E449A	E	449	A	1346A>C	A	C	biliary_tract	carcinoma	adenocarcinoma	NS	Unknown	ENST00000369060.8	449	P21802	565	cosmicV97nov2022
FGFR2_ENST00000360144	No	BGJ398	E477A	E	477	A	1430A>C	A	C	biliary_tract	carcinoma	adenocarcinoma	NS	Unknown	ENST00000360144.7	477	P21802	565	cosmicV97nov2022
FGFR2_ENST00000369061	No	INCB054828	N437H	N	437	H	1309A>C	A	C	biliary_tract	carcinoma	adenocarcinoma	NS	Unknown	ENST00000369061.8	437	P21802	549	cosmicV97nov2022
EGFR	Yes	Gefitinib	T790M	T	790	M	2369C>T	C	T	lung	carcinoma	adenocarcinoma	NS	Unknown	ENST00000275493.6	790	P00533	790	cosmicV97nov2022
ABL1_ENST00000318560	No	Imatinib	T315I	T	315	I	944C>T	C	T	haematopoietic_and_lymphoid_tissue	haematopoietic_neoplasm	chronic_myeloid_leukaemia	Ph_positive	Unknown	ENST00000318560.5	315	P00519	315	cosmicV97nov2022
ABL1_ENST00000318560	No	Imatinib	F317L	F	317	L	951C>G	C	G	haematopoietic_and_lymphoid_tissue	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	Unknown	ENST00000318560.5	317	P00519	317	cosmicV97nov2022
EGFR	Yes	Afatinib	T790M	T	790	M	?	?	NA	lung	carcinoma	adenocarcinoma	NS	Unknown	ENST00000275493.6	790	P00533	790	cosmicV97nov2022
KIT	Yes	Imatinib	D820E	D	820	E	?	?	NA	soft_tissue	gastrointestinal_stromal_tumour	NS	NS	Unknown	ENST00000288135.5	820	P10721	820	cosmicV97nov2022
EGFR_ENST00000455089	No	Osimertinib	C752G	C	752	G	2254T>G	T	G	lung	carcinoma	adenocarcinoma	NS	Unknown	ENST00000455089.5	752	P00533	797	cosmicV97nov2022
BTK	Yes	Ibrutinib	C515S	C	515	S	1544G>C	G	C	haematopoietic_and_lymphoid_tissue	lymphoid_neoplasm	chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma	NS	Unknown	ENST00000621635.4	515	Q06187	481	cosmicV97nov2022
ALK	Yes	Crizotinib	L1196M	L	1196	M	?	?	NA	lung	carcinoma	non_small_cell_carcinoma	NS	Unknown	ENST00000389048.7	1196	Q9UM73	1196	cosmicV97nov2022
EGFR_ENST00000454757	No	Osimertinib	L747F	L	747	F	2239C>T	C	T	lung	carcinoma	adenocarcinoma	NS	Unknown	ENST00000454757.6	747	P00533	792	cosmicV97nov2022
EGFR	Yes	Osimertinib	C797S	C	797	S	2390G>C	G	C	lung	carcinoma	adenocarcinoma	NS	Unknown	ENST00000275493.6	797	P00533	797	cosmicV97nov2022
EGFR	Yes	Osimertinib	C797S	C	797	S	2389T>A	T	A	lung	carcinoma	adenocarcinoma	NS	Unknown	ENST00000275493.6	797	P00533	797	cosmicV97nov2022
FGFR2_ENST00000358487	No	FGFR	N549D	N	549	D	?	?	NA	biliary_tract	carcinoma	adenocarcinoma	NS	Unknown	ENST00000358487.9	549	P21802	549	cosmicV97nov2022
KIT	Yes	Imatinib	V654A	V	654	A	1961T>C	T	C	soft_tissue	gastrointestinal_stromal_tumour	epithelioid	NS	Unknown	ENST00000288135.5	654	P10721	654	cosmicV97nov2022
BTK_ENST00000308731	No	Ibrutinib	C481Y	C	481	Y	1442G>A	G	A	haematopoietic_and_lymphoid_tissue	lymphoid_neoplasm	lymphoplasmacytic_lymphoma	NS	Unknown	ENST00000308731.7	481	Q06187	481	cosmicV97nov2022
BTK_ENST00000618050	No	Ibrutinib	C481Y	C	481	Y	1442G>A	G	A	haematopoietic_and_lymphoid_tissue	lymphoid_neoplasm	chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma	NS	Unknown	ENST00000618050.4	481	Q06187	481	cosmicV97nov2022
BTK	Yes	Ibrutinib	C515R	C	515	R	1543T>C	T	C	haematopoietic_and_lymphoid_tissue	lymphoid_neoplasm	chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma	NS	Unknown	ENST00000621635.4	515	Q06187	481	cosmicV97nov2022
EGFR	Yes	Osimertinib	L718Q	L	718	Q	2153T>A	T	A	lung	carcinoma	non_small_cell_carcinoma	NS	Unknown	ENST00000275493.6	718	P00533	718	cosmicV97nov2022
EGFR_ENST00000455089	No	Osimertinib	C752S	C	752	S	2254T>A	T	A	lung	carcinoma	adenocarcinoma	NS	Unknown	ENST00000455089.5	752	P00533	797	cosmicV97nov2022
EGFR_ENST00000455089	No	Osimertinib	L673Q	L	673	Q	2018T>A	T	A	lung	carcinoma	adenocarcinoma	NS	Unknown	ENST00000455089.5	673	P00533	718	cosmicV97nov2022
FGFR1_ENST00000326324	No	Palbociclib	N455K	N	455	K	1365C>A	C	A	breast	carcinoma	ER-positive_carcinoma	NS	Unknown	ENST00000326324.10	455	P11362	546	cosmicV97nov2022
EGFR_ENST00000454757	No	Erlotinib	T745M	T	745	M	2234C>T	C	T	lung	carcinoma	bronchioloalveolar_adenocarcinoma	NS	Unknown	ENST00000454757.6	745	P00533	790	cosmicV97nov2022
EGFR	Yes	Gefitinib	T790M	T	790	M	2369C>T	C	T	lung	carcinoma	adenocarcinoma	NS	Heterozygous	ENST00000275493.6	790	P00533	790	cosmicV97nov2022
EGFR	Yes	Tyrosine kinase inhibitor - NS	T790M	T	790	M	2369C>T	C	T	lung	carcinoma	adenocarcinoma	NS	Heterozygous	ENST00000275493.6	790	P00533	790	cosmicV97nov2022
ALK	Yes	Crizotinib	L1196M	L	1196	M	3586C>A	C	A	lung	carcinoma	non_small_cell_carcinoma	NS	Unknown	ENST00000389048.7	1196	Q9UM73	1196	cosmicV97nov2022
BTK_ENST00000618050	No	Ibrutinib	C481S	C	481	S	1442_1443delinsCT	T	NA	haematopoietic_and_lymphoid_tissue	lymphoid_neoplasm	mantle_cell_lymphoma	NS	Unknown	ENST00000618050.4	481	Q06187	481	cosmicV97nov2022
BTK	Yes	Ibrutinib	C515Y	C	515	Y	1544G>A	G	A	haematopoietic_and_lymphoid_tissue	lymphoid_neoplasm	chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma	NS	Unknown	ENST00000621635.4	515	Q06187	481	cosmicV97nov2022
EGFR_ENST00000454757	No	Osimertinib	C752S	C	752	S	2254T>A	T	A	lung	carcinoma	non_small_cell_carcinoma	NS	Heterozygous	ENST00000454757.6	752	P00533	797	cosmicV97nov2022
ALK	Yes	Alectinib	G1202R	G	1202	R	3604G>A	G	A	lung	carcinoma	adenocarcinoma	NS	Unknown	ENST00000389048.7	1202	Q9UM73	1202	cosmicV97nov2022
EGFR_ENST00000454757	No	Osimertinib	L747H	L	747	H	2240T>A	T	A	lung	carcinoma	adenocarcinoma	NS	Unknown	ENST00000454757.6	747	P00533	792	cosmicV97nov2022
FGFR2_ENST00000358487	No	TAS-120	N549K	N	549	K	?	?	NA	biliary_tract	carcinoma	adenocarcinoma	NS	Unknown	ENST00000358487.9	549	P21802	549	cosmicV97nov2022
FGFR2_ENST00000351936	No	BGJ398	E565A	E	565	A	1694A>C	A	C	biliary_tract	carcinoma	adenocarcinoma	NS	Unknown	ENST00000351936.10	565	P21802	565	cosmicV97nov2022
FGFR2_ENST00000358487	No	BGJ398	E565A	E	565	A	1694A>C	A	C	biliary_tract	carcinoma	adenocarcinoma	NS	Unknown	ENST00000358487.9	565	P21802	565	cosmicV97nov2022
ABL1	Yes	Imatinib	F336L	F	336	L	1008C>G	C	G	haematopoietic_and_lymphoid_tissue	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	Unknown	ENST00000372348.6	336	P00519	317	cosmicV97nov2022
EGFR	Yes	Tyrosine kinase inhibitor - NS	T790M	T	790	M	2369C>T	C	T	lung	carcinoma	adenocarcinoma	NS	Unknown	ENST00000275493.6	790	P00533	790	cosmicV97nov2022
FLT3	Yes	Quizartinib	D835V	D	835	V	2504A>T	A	T	haematopoietic_and_lymphoid_tissue	haematopoietic_neoplasm	acute_myeloid_leukaemia	NS	Unknown	ENST00000241453.11	835	P36888	835	cosmicV97nov2022
EGFR_ENST00000454757	No	Gefitinib	T745M	T	745	M	2234C>T	C	T	lung	carcinoma	non_small_cell_carcinoma	NS	Unknown	ENST00000454757.6	745	P00533	790	cosmicV97nov2022
BTK_ENST00000618050	No	Ibrutinib	C481S	C	481	S	1442G>C	G	C	haematopoietic_and_lymphoid_tissue	lymphoid_neoplasm	lymphoplasmacytic_lymphoma	NS	Unknown	ENST00000618050.4	481	Q06187	481	cosmicV97nov2022
FGFR2	Yes	BGJ398	L618M	L	618	M	1852T>A	T	A	biliary_tract	carcinoma	adenocarcinoma	NS	Unknown	ENST00000457416.6	618	P21802	617	cosmicV97nov2022
FGFR2_ENST00000346997	No	BGJ398	L615M	L	615	M	1843T>A	T	A	biliary_tract	carcinoma	adenocarcinoma	NS	Unknown	ENST00000346997.6	615	P21802	617	cosmicV97nov2022
EGFR_ENST00000455089	No	Erlotinib	T745M	T	745	M	2234C>T	C	T	lung	carcinoma	non_small_cell_carcinoma	NS	Unknown	ENST00000455089.5	745	P00533	790	cosmicV97nov2022
KDR	Yes	Cetuximab	L840F	L	840	F	2518C>T	C	T	large_intestine	carcinoma	adenocarcinoma	NS	Heterozygous	ENST00000645273.1	840	P35968	840	cosmicV97nov2022
KIT	Yes	Imatinib	N822K	N	822	K	?	?	NA	soft_tissue	gastrointestinal_stromal_tumour	spindle_and_epithelioid	NS	Unknown	ENST00000288135.5	822	P10721	822	cosmicV97nov2022
ERBB2_ENST00000406381	No	Trastuzumab	L839R	L	839	R	2516T>G	T	G	breast	carcinoma	ductal_carcinoma	NS	Unknown	ENST00000406381.6	839	P04626	869	cosmicV97nov2022
KIT	Yes	Imatinib	D816E	D	816	E	?	?	NA	soft_tissue	gastrointestinal_stromal_tumour	NS	NS	Unknown	ENST00000288135.5	816	P10721	816	cosmicV97nov2022
KIT	Yes	Imatinib	A829P	A	829	P	?	?	NA	soft_tissue	gastrointestinal_stromal_tumour	NS	NS	Unknown	ENST00000288135.5	829	P10721	829	cosmicV97nov2022
ALK_ENST00000618119	No	Alectinib	G825R	G	825	R	2473G>A	G	A	lung	carcinoma	non_small_cell_carcinoma	NS	Unknown	ENST00000618119.4	825	Q9UM73	1202	cosmicV97nov2022
EGFR	Yes	Afatinib	T790M	T	790	M	?	?	NA	lung	carcinoma	non_small_cell_carcinoma	NS	Unknown	ENST00000275493.6	790	P00533	790	cosmicV97nov2022
BTK_ENST00000308731	No	Ibrutinib	C481S	C	481	S	1442_1443delinsCT	T	NA	haematopoietic_and_lymphoid_tissue	lymphoid_neoplasm	mantle_cell_lymphoma	NS	Unknown	ENST00000308731.7	481	Q06187	481	cosmicV97nov2022
BTK	Yes	Ibrutinib	C515S	C	515	S	1544G>C	G	C	haematopoietic_and_lymphoid_tissue	lymphoid_neoplasm	mantle_cell_lymphoma	NS	Unknown	ENST00000621635.4	515	Q06187	481	cosmicV97nov2022
EGFR	Yes	Osimertinib	L792F	L	792	F	2374C>T	C	T	lung	carcinoma	adenocarcinoma	NS	Unknown	ENST00000275493.6	792	P00533	792	cosmicV97nov2022
EGFR	Yes	Osimertinib	G796R	G	796	R	2386G>C	G	C	lung	carcinoma	adenocarcinoma	NS	Unknown	ENST00000275493.6	796	P00533	796	cosmicV97nov2022
EGFR	Yes	Erlotinib	T790M	T	790	M	2369C>T	C	T	lung	carcinoma	non_small_cell_carcinoma	NS	Heterozygous	ENST00000275493.6	790	P00533	790	cosmicV97nov2022
EGFR_ENST00000454757	No	Osimertinib	C752S	C	752	S	2255G>C	G	C	lung	carcinoma	adenocarcinoma	NS	Unknown	ENST00000454757.6	752	P00533	797	cosmicV97nov2022
EGFR	Yes	Osimertinib	L792R	L	792	R	2375T>G	T	G	lung	carcinoma	small_cell_carcinoma	NS	Unknown	ENST00000275493.6	792	P00533	792	cosmicV97nov2022
EGFR	Yes	Osimertinib	G719A	G	719	A	2156G>C	G	C	lung	carcinoma	adenocarcinoma	NS	Unknown	ENST00000275493.6	719	P00533	719	cosmicV97nov2022
MAP2K2_ENST00000394867	No	Dabrafenib	N29D	N	29	D	85A>G	A	G	NS	malignant_melanoma	NS	NS	Unknown	ENST00000394867.8	29	P36507	126	cosmicV97nov2022
ABL1_ENST00000318560	No	Imatinib	D276G	D	276	G	827A>G	A	G	haematopoietic_and_lymphoid_tissue	lymphoid_neoplasm	acute_lymphoblastic_leukaemia	Ph_positive	Unknown	ENST00000318560.5	276	P00519	276	cosmicV97nov2022
EGFR_ENST00000454757	No	Erlotinib	T745M	T	745	M	2234C>T	C	T	lung	carcinoma	adenocarcinoma	NS	Heterozygous	ENST00000454757.6	745	P00533	790	cosmicV97nov2022
ALK	Yes	Crizotinib	F1174L	F	1174	L	3522C>G	C	G	soft_tissue	inflammatory_myofibroblastic_tumour	NS	NS	Homozygous	ENST00000389048.7	1174	Q9UM73	1174	cosmicV97nov2022
ABL1_ENST00000318560	No	Tyrosine kinase inhibitor - NS	T315I	T	315	I	?	?	NA	haematopoietic_and_lymphoid_tissue	lymphoid_neoplasm	acute_lymphoblastic_leukaemia	Ph_positive	Unknown	ENST00000318560.5	315	P00519	315	cosmicV97nov2022
EGFR	Yes	Erlotinib	T790M	T	790	M	?	?	NA	lung	carcinoma	acinar_adenocarcinoma	NS	Unknown	ENST00000275493.6	790	P00533	790	cosmicV97nov2022
KIT	Yes	Imatinib	K642E	K	642	E	?	?	NA	soft_tissue	gastrointestinal_stromal_tumour	spindle	NS	Unknown	ENST00000288135.5	642	P10721	642	cosmicV97nov2022
EGFR	Yes	Osimertinib	L747P	L	747	P	2239_2240delinsCC	C	NA	lung	carcinoma	adenocarcinoma	NS	Unknown	ENST00000275493.6	747	P00533	747	cosmicV97nov2022
EGFR_ENST00000455089	No	Osimertinib	C752S	C	752	S	2255G>C	G	C	lung	carcinoma	adenocarcinoma	NS	Unknown	ENST00000455089.5	752	P00533	797	cosmicV97nov2022
EGFR_ENST00000454757	No	Osimertinib	C752S	C	752	S	2255G>C	G	C	lung	carcinoma	small_cell_carcinoma	NS	Unknown	ENST00000454757.6	752	P00533	797	cosmicV97nov2022
FGFR2_ENST00000357555	No	BGJ398	E476A	E	476	A	1427A>C	A	C	biliary_tract	carcinoma	adenocarcinoma	NS	Unknown	ENST00000357555.9	476	P21802	565	cosmicV97nov2022
FGFR2_ENST00000369061	No	BGJ398	L505M	L	505	M	1513T>A	T	A	biliary_tract	carcinoma	adenocarcinoma	NS	Unknown	ENST00000369061.8	505	P21802	617	cosmicV97nov2022
ALK_ENST00000642122	No	Crizotinib	L128M	L	128	M	382C>A	C	A	lung	carcinoma	adenocarcinoma	NS	Unknown	ENST00000642122.1	128	Q9UM73	1196	cosmicV97nov2022
ABL1_ENST00000318560	No	Imatinib	Y253H	Y	253	H	?	?	NA	haematopoietic_and_lymphoid_tissue	haematopoietic_neoplasm	chronic_myeloid_leukaemia	Ph_positive	Unknown	ENST00000318560.5	253	P00519	253	cosmicV97nov2022
EGFR	Yes	Gefitinib	T790M	T	790	M	2369C>T	C	T	lung	carcinoma	squamous_cell_carcinoma	NS	Unknown	ENST00000275493.6	790	P00533	790	cosmicV97nov2022
KIT	Yes	Imatinib	C809G	C	809	G	?	?	NA	soft_tissue	gastrointestinal_stromal_tumour	NS	NS	Unknown	ENST00000288135.5	809	P10721	809	cosmicV97nov2022
FGFR4	Yes	Fisogatinib	V550L	V	550	L	1648G>T	G	T	liver	carcinoma	hepatocellular_carcinoma	NS	Unknown	ENST00000292408.8	550	P22455	550	cosmicV97nov2022
FGFR4_ENST00000393648	No	Fisogatinib	V482L	V	482	L	1444G>T	G	T	liver	carcinoma	hepatocellular_carcinoma	NS	Unknown	ENST00000393648.6	482	P22455	550	cosmicV97nov2022
ALK	Yes	Lorlatinib	L1196M	L	1196	M	?	?	NA	lung	carcinoma	non_small_cell_carcinoma	NS	Unknown	ENST00000389048.7	1196	Q9UM73	1196	cosmicV97nov2022
EGFR_ENST00000455089	No	Osimertinib	L747F	L	747	F	2239C>T	C	T	lung	carcinoma	adenocarcinoma	NS	Unknown	ENST00000455089.5	747	P00533	792	cosmicV97nov2022
EGFR_ENST00000455089	No	Osimertinib	L747H	L	747	H	2240T>A	T	A	lung	carcinoma	adenocarcinoma	NS	Unknown	ENST00000455089.5	747	P00533	792	cosmicV97nov2022
FGFR2	Yes	BGJ398	E566A	E	566	A	1697A>C	A	C	biliary_tract	carcinoma	adenocarcinoma	NS	Unknown	ENST00000457416.6	566	P21802	565	cosmicV97nov2022
FGFR2_ENST00000369059	No	BGJ398	E451A	E	451	A	1352A>C	A	C	biliary_tract	carcinoma	adenocarcinoma	NS	Unknown	ENST00000369059.5	451	P21802	565	cosmicV97nov2022
MET_ENST00000397752	No	Crizotinib	D1228N	D	1228	N	3682G>A	G	A	breast	carcinoma	basal_(triple-negative)_carcinoma	NS	Unknown	ENST00000397752.7	1228	P08581	1228	cosmicV97nov2022
MAP2K1	Yes	Vemurafenib	P124L	P	124	L	371C>T	C	T	NS	malignant_melanoma	NS	NS	Unknown	ENST00000307102.9	124	Q02750	124	cosmicV97nov2022
PDGFRA	Yes	Imatinib	D842V	D	842	V	2525A>T	A	T	soft_tissue	gastrointestinal_stromal_tumour	NS	NS	Unknown	ENST00000257290.9	842	P16234	842	cosmicV97nov2022
ABL1_ENST00000318560	No	Dasatinib	Y253H	Y	253	H	?	?	NA	haematopoietic_and_lymphoid_tissue	haematopoietic_neoplasm	blast_phase_chronic_myeloid_leukaemia	NS	Unknown	ENST00000318560.5	253	P00519	253	cosmicV97nov2022
MET	Yes	Crizotinib	D1246N	D	1246	N	?	?	NA	lung	carcinoma	adenocarcinoma	NS	Unknown	ENST00000318493.10	1246	P08581	1228	cosmicV97nov2022
FGFR4_ENST00000393637	No	Fisogatinib	V510L	V	510	L	1528G>T	G	T	liver	carcinoma	hepatocellular_carcinoma	NS	Unknown	ENST00000393637.5	510	P22455	550	cosmicV97nov2022
FGFR4_ENST00000393648	No	Fisogatinib	V482M	V	482	M	1444G>A	G	A	liver	carcinoma	hepatocellular_carcinoma	NS	Unknown	ENST00000393648.6	482	P22455	550	cosmicV97nov2022
BTK_ENST00000308731	No	Acalabrutinib	C481S	C	481	S	1442G>C	G	C	haematopoietic_and_lymphoid_tissue	lymphoid_neoplasm	chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma	Richter_transformation	Unknown	ENST00000308731.7	481	Q06187	481	cosmicV97nov2022
ABL1_ENST00000318560	No	Imatinib	T315I	T	315	I	944C>T	C	T	haematopoietic_and_lymphoid_tissue	haematopoietic_neoplasm	blast_phase_chronic_myeloid_leukaemia	NS	Unknown	ENST00000318560.5	315	P00519	315	cosmicV97nov2022
ABL1_ENST00000318560	No	Imatinib	T315I	T	315	I	?	?	NA	haematopoietic_and_lymphoid_tissue	lymphoid_neoplasm	acute_lymphoblastic_leukaemia	NS	Unknown	ENST00000318560.5	315	P00519	315	cosmicV97nov2022
ABL1_ENST00000318560	No	Imatinib	G250E	G	250	E	?	?	NA	haematopoietic_and_lymphoid_tissue	haematopoietic_neoplasm	blast_phase_chronic_myeloid_leukaemia	NS	Unknown	ENST00000318560.5	250	P00519	250	cosmicV97nov2022
EGFR_ENST00000454757	No	Erlotinib	T745M	T	745	M	2234C>T	C	T	lung	carcinoma	adenocarcinoma	NS	Unknown	ENST00000454757.6	745	P00533	790	cosmicV97nov2022
KIT	Yes	Imatinib	D820G	D	820	G	?	?	NA	soft_tissue	gastrointestinal_stromal_tumour	spindle	NS	Unknown	ENST00000288135.5	820	P10721	820	cosmicV97nov2022
BTK	Yes	Ibrutinib	C515S	C	515	S	1544_1545delinsCT	T	NA	haematopoietic_and_lymphoid_tissue	lymphoid_neoplasm	mantle_cell_lymphoma	NS	Unknown	ENST00000621635.4	515	Q06187	481	cosmicV97nov2022
EGFR_ENST00000454757	No	Osimertinib	G751R	G	751	R	2251G>C	G	C	lung	carcinoma	adenocarcinoma	NS	Unknown	ENST00000454757.6	751	P00533	796	cosmicV97nov2022
MET_ENST00000397752	No	Crizotinib	D1228N	D	1228	N	3682G>A	G	A	lung	carcinoma	adenocarcinoma	NS	Unknown	ENST00000397752.7	1228	P08581	1228	cosmicV97nov2022
BTK_ENST00000618050	No	Acalabrutinib	C481S	C	481	S	1442G>C	G	C	haematopoietic_and_lymphoid_tissue	lymphoid_neoplasm	chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma	Richter_transformation	Unknown	ENST00000618050.4	481	Q06187	481	cosmicV97nov2022
KIT	Yes	Imatinib	T670I	T	670	I	2009C>T	C	T	soft_tissue	gastrointestinal_stromal_tumour	spindle	NS	Heterozygous	ENST00000288135.5	670	P10721	670	cosmicV97nov2022
FGFR2_ENST00000369060	No	INCB054828	N433H	N	433	H	1297A>C	A	C	biliary_tract	carcinoma	adenocarcinoma	NS	Unknown	ENST00000369060.8	433	P21802	549	cosmicV97nov2022
EGFR_ENST00000455089	No	Tyrosine kinase inhibitor - NS	T745M	T	745	M	2234C>T	C	T	lung	carcinoma	adenocarcinoma	NS	Heterozygous	ENST00000455089.5	745	P00533	790	cosmicV97nov2022
ALK_ENST00000642122	No	Crizotinib	G134R	G	134	R	400G>A	G	A	lung	carcinoma	adenocarcinoma	NS	Unknown	ENST00000642122.1	134	Q9UM73	1202	cosmicV97nov2022
ALK	Yes	Crizotinib	C1156Y	C	1156	Y	3467G>A	G	A	lung	carcinoma	non_small_cell_carcinoma	NS	Unknown	ENST00000389048.7	1156	Q9UM73	1156	cosmicV97nov2022
KIT	Yes	Imatinib	D820Y	D	820	Y	?	?	NA	soft_tissue	gastrointestinal_stromal_tumour	spindle	NS	Unknown	ENST00000288135.5	820	P10721	820	cosmicV97nov2022
BTK_ENST00000618050	No	Ibrutinib	C481S	C	481	S	1441T>A	T	A	haematopoietic_and_lymphoid_tissue	lymphoid_neoplasm	lymphoplasmacytic_lymphoma	NS	Unknown	ENST00000618050.4	481	Q06187	481	cosmicV97nov2022
EGFR	Yes	Osimertinib	L718Q	L	718	Q	2153T>A	T	A	lung	carcinoma	adenocarcinoma	NS	Homozygous	ENST00000275493.6	718	P00533	718	cosmicV97nov2022
EGFR_ENST00000454757	No	Osimertinib	L747H	L	747	H	2240T>A	T	A	lung	carcinoma	non_small_cell_carcinoma	NS	Heterozygous	ENST00000454757.6	747	P00533	792	cosmicV97nov2022
EGFR	Yes	Osimertinib	L792H	L	792	H	2375T>A	T	A	lung	carcinoma	adenocarcinoma	NS	Unknown	ENST00000275493.6	792	P00533	792	cosmicV97nov2022
FGFR1_ENST00000397091	No	Palbociclib	N544K	N	544	K	1632C>A	C	A	breast	carcinoma	ER-positive_carcinoma	NS	Unknown	ENST00000397091.9	544	P11362	546	cosmicV97nov2022
EGFR_ENST00000454757	No	Gefitinib	T745M	T	745	M	2234C>T	C	T	lung	carcinoma	bronchioloalveolar_adenocarcinoma	NS	Unknown	ENST00000454757.6	745	P00533	790	cosmicV97nov2022
ALK	Yes	Crizotinib	L1196M	L	1196	M	3586C>A	C	A	lung	carcinoma	adenocarcinoma	NS	Unknown	ENST00000389048.7	1196	Q9UM73	1196	cosmicV97nov2022
FLT3	Yes	Quizartinib	D835Y	D	835	Y	2503G>T	G	T	haematopoietic_and_lymphoid_tissue	haematopoietic_neoplasm	acute_myeloid_leukaemia	NS	Unknown	ENST00000241453.11	835	P36888	835	cosmicV97nov2022
ALK	Yes	Crizotinib	F1174V	F	1174	V	3520T>G	T	G	lung	carcinoma	mixed_adenosquamous_carcinoma	NS	Heterozygous	ENST00000389048.7	1174	Q9UM73	1174	cosmicV97nov2022
EGFR	Yes	Afatinib	T790M	T	790	M	2369C>T	C	T	lung	carcinoma	bronchioloalveolar_adenocarcinoma	NS	Unknown	ENST00000275493.6	790	P00533	790	cosmicV97nov2022
KIT	Yes	Imatinib	N822Y	N	822	Y	2464A>T	A	T	soft_tissue	gastrointestinal_stromal_tumour	spindle_and_epithelioid	NS	Unknown	ENST00000288135.5	822	P10721	822	cosmicV97nov2022
BRAF	Yes	Vemurafenib	L505H	L	505	H	1514T>A	T	A	skin	malignant_melanoma	NS	NS	Unknown	ENST00000646891.1	505	P15056	505	cosmicV97nov2022
MET_ENST00000397752	No	Crizotinib	Y1230C	Y	1230	C	3689A>G	A	G	lung	carcinoma	adenocarcinoma	NS	Unknown	ENST00000397752.7	1230	P08581	1230	cosmicV97nov2022
BTK	Yes	Ibrutinib	C515S	C	515	S	1544G>C	G	C	haematopoietic_and_lymphoid_tissue	lymphoid_neoplasm	lymphoplasmacytic_lymphoma	NS	Unknown	ENST00000621635.4	515	Q06187	481	cosmicV97nov2022
BTK	Yes	Ibrutinib	C515S	C	515	S	1543T>A	T	A	haematopoietic_and_lymphoid_tissue	lymphoid_neoplasm	chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma	NS	Homozygous	ENST00000621635.4	515	Q06187	481	cosmicV97nov2022
BTK_ENST00000308731	No	Ibrutinib	C481S	C	481	S	1442G>C	G	C	haematopoietic_and_lymphoid_tissue	lymphoid_neoplasm	mantle_cell_lymphoma	NS	Unknown	ENST00000308731.7	481	Q06187	481	cosmicV97nov2022
ALK	Yes	Lorlatinib	G1202R	G	1202	R	3604G>A	G	A	lung	carcinoma	adenocarcinoma	NS	Unknown	ENST00000389048.7	1202	Q9UM73	1202	cosmicV97nov2022
BTK_ENST00000618050	No	Ibrutinib	C481S	C	481	S	1441T>A	T	A	haematopoietic_and_lymphoid_tissue	lymphoid_neoplasm	chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma	Richter_transformation	Unknown	ENST00000618050.4	481	Q06187	481	cosmicV97nov2022
EGFR_ENST00000454757	No	Osimertinib	L673V	L	673	V	2017C>G	C	G	lung	carcinoma	adenocarcinoma	NS	Unknown	ENST00000454757.6	673	P00533	718	cosmicV97nov2022
FGFR2_ENST00000369061	No	BGJ398	E453A	E	453	A	1358A>C	A	C	biliary_tract	carcinoma	adenocarcinoma	NS	Unknown	ENST00000369061.8	453	P21802	565	cosmicV97nov2022
FGFR2_ENST00000613048	No	BGJ398	E476A	E	476	A	1427A>C	A	C	biliary_tract	carcinoma	adenocarcinoma	NS	Unknown	ENST00000613048.4	476	P21802	565	cosmicV97nov2022
ABL1_ENST00000318560	No	Imatinib	F311I	F	311	I	?	?	NA	haematopoietic_and_lymphoid_tissue	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	Unknown	ENST00000318560.5	311	P00519	311	cosmicV97nov2022
ABL1_ENST00000318560	No	Imatinib	Y253H	Y	253	H	?	?	NA	haematopoietic_and_lymphoid_tissue	lymphoid_neoplasm	acute_lymphoblastic_leukaemia	NS	Unknown	ENST00000318560.5	253	P00519	253	cosmicV97nov2022
PDGFRA	Yes	Sunitinib	D842V	D	842	V	?	?	NA	soft_tissue	gastrointestinal_stromal_tumour	NS	NS	Unknown	ENST00000257290.9	842	P16234	842	cosmicV97nov2022
FLT3	Yes	Sorafenib	D835X	D	835	X	?	?	NA	haematopoietic_and_lymphoid_tissue	haematopoietic_neoplasm	acute_myeloid_leukaemia	NS	Heterozygous	ENST00000241453.11	835	P36888	835	cosmicV97nov2022
BTK_ENST00000308731	No	Ibrutinib	C481S	C	481	S	1441T>A	T	A	haematopoietic_and_lymphoid_tissue	lymphoid_neoplasm	lymphoplasmacytic_lymphoma	NS	Unknown	ENST00000308731.7	481	Q06187	481	cosmicV97nov2022
BTK_ENST00000308731	No	Ibrutinib	C481S	C	481	S	1441T>A	T	A	haematopoietic_and_lymphoid_tissue	lymphoid_neoplasm	chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma	NS	Homozygous	ENST00000308731.7	481	Q06187	481	cosmicV97nov2022
EGFR_ENST00000454757	No	Osimertinib	L747F	L	747	F	2239C>T	C	T	lung	carcinoma	non_small_cell_carcinoma	NS	Heterozygous	ENST00000454757.6	747	P00533	792	cosmicV97nov2022
EGFR_ENST00000455089	No	Osimertinib	G674A	G	674	A	2021G>C	G	C	lung	carcinoma	adenocarcinoma	NS	Unknown	ENST00000455089.5	674	P00533	719	cosmicV97nov2022
ABL1	Yes	Imatinib	T334I	T	334	I	1001C>T	C	T	haematopoietic_and_lymphoid_tissue	haematopoietic_neoplasm	blast_phase_chronic_myeloid_leukaemia	NS	Unknown	ENST00000372348.6	334	P00519	315	cosmicV97nov2022
EGFR	Yes	Erlotinib	T790M	T	790	M	?	?	NA	lung	carcinoma	non_small_cell_carcinoma	NS	Unknown	ENST00000275493.6	790	P00533	790	cosmicV97nov2022
ABL1	Yes	Imatinib	T334I	T	334	I	1001C>T	C	T	haematopoietic_and_lymphoid_tissue	haematopoietic_neoplasm	chronic_myeloid_leukaemia	Ph_positive	Unknown	ENST00000372348.6	334	P00519	315	cosmicV97nov2022
ABL1_ENST00000318560	No	Dasatinib	T315I	T	315	I	?	?	NA	haematopoietic_and_lymphoid_tissue	haematopoietic_neoplasm	blast_phase_chronic_myeloid_leukaemia	NS	Unknown	ENST00000318560.5	315	P00519	315	cosmicV97nov2022
ALK	Yes	Crizotinib	S1206F	S	1206	F	?	?	NA	lung	carcinoma	non_small_cell_carcinoma	NS	Unknown	ENST00000389048.7	1206	Q9UM73	1206	cosmicV97nov2022
FGFR2_ENST00000358487	No	TAS-120	V564F	V	564	F	?	?	NA	biliary_tract	carcinoma	adenocarcinoma	NS	Unknown	ENST00000358487.9	564	P21802	564	cosmicV97nov2022
MAP2K1	Yes	Vemurafenib	G128V	G	128	V	383G>T	G	T	NS	malignant_melanoma	NS	NS	Unknown	ENST00000307102.9	128	Q02750	128	cosmicV97nov2022
MAP2K1	Yes	Vemurafenib	C121S	C	121	S	362G>C	G	C	NS	malignant_melanoma	NS	NS	Unknown	ENST00000307102.9	121	Q02750	121	cosmicV97nov2022
ABL1_ENST00000318560	No	Dasatinib	F317L	F	317	L	?	?	NA	haematopoietic_and_lymphoid_tissue	lymphoid_neoplasm	acute_lymphoblastic_leukaemia	Ph_positive	Unknown	ENST00000318560.5	317	P00519	317	cosmicV97nov2022
ALK_ENST00000642122	No	Alectinib	G134R	G	134	R	400G>A	G	A	lung	carcinoma	non_small_cell_carcinoma	NS	Unknown	ENST00000642122.1	134	Q9UM73	1202	cosmicV97nov2022
EGFR_ENST00000454757	No	HM61713	C752S	C	752	S	2255G>C	G	C	lung	carcinoma	adenocarcinoma	NS	Unknown	ENST00000454757.6	752	P00533	797	cosmicV97nov2022
BTK_ENST00000308731	No	Ibrutinib	C481R	C	481	R	1441T>C	T	C	haematopoietic_and_lymphoid_tissue	lymphoid_neoplasm	lymphoplasmacytic_lymphoma	NS	Unknown	ENST00000308731.7	481	Q06187	481	cosmicV97nov2022
ALK_ENST00000642122	No	Lorlatinib	G134R	G	134	R	400G>A	G	A	lung	carcinoma	adenocarcinoma	NS	Unknown	ENST00000642122.1	134	Q9UM73	1202	cosmicV97nov2022
EGFR_ENST00000454757	No	Osimertinib	L673Q	L	673	Q	2018T>A	T	A	lung	carcinoma	non_small_cell_carcinoma	NS	Unknown	ENST00000454757.6	673	P00533	718	cosmicV97nov2022
MAP2K1	Yes	Vemurafenib	C121S	C	121	S	361T>A	T	A	skin	malignant_melanoma	NS	NS	Unknown	ENST00000307102.9	121	Q02750	121	cosmicV97nov2022
FGFR1_ENST00000397108	No	Palbociclib	N544K	N	544	K	1632C>A	C	A	breast	carcinoma	ER-positive_carcinoma	NS	Unknown	ENST00000397108.8	544	P11362	546	cosmicV97nov2022
FGFR2_ENST00000356226	No	Palbociclib	N432K	N	432	K	1296T>A	T	A	breast	carcinoma	ER-positive_carcinoma	NS	Unknown	ENST00000356226.8	432	P21802	549	cosmicV97nov2022
FGFR2_ENST00000478859	No	BGJ398	E337A	E	337	A	1010A>C	A	C	biliary_tract	carcinoma	adenocarcinoma	NS	Unknown	ENST00000478859.5	337	P21802	565	cosmicV97nov2022
EGFR_ENST00000454757	No	Erlotinib	T745M	T	745	M	2234C>T	C	T	lung	carcinoma	non_small_cell_carcinoma	NS	Unknown	ENST00000454757.6	745	P00533	790	cosmicV97nov2022
KIT	Yes	Imatinib	V654A	V	654	A	1961T>C	T	C	soft_tissue	gastrointestinal_stromal_tumour	spindle_and_epithelioid	NS	Heterozygous	ENST00000288135.5	654	P10721	654	cosmicV97nov2022
EGFR_ENST00000455089	No	Tyrosine kinase inhibitor - NS	T745M	T	745	M	2234C>T	C	T	lung	carcinoma	adenocarcinoma	NS	Unknown	ENST00000455089.5	745	P00533	790	cosmicV97nov2022
ABL1_ENST00000318560	No	Nilotinib	T315I	T	315	I	?	?	NA	haematopoietic_and_lymphoid_tissue	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	Unknown	ENST00000318560.5	315	P00519	315	cosmicV97nov2022
ABL1_ENST00000318560	No	Dasatinib	E255K	E	255	K	?	?	NA	haematopoietic_and_lymphoid_tissue	haematopoietic_neoplasm	blast_phase_chronic_myeloid_leukaemia	NS	Unknown	ENST00000318560.5	255	P00519	255	cosmicV97nov2022
BRAF_ENST00000644969	No	Vemurafenib	L545H	L	545	H	1634T>A	T	A	skin	malignant_melanoma	NS	NS	Unknown	ENST00000644969.1	545	P15056	505	cosmicV97nov2022
BTK_ENST00000618050	No	Ibrutinib	C481R	C	481	R	1441T>C	T	C	haematopoietic_and_lymphoid_tissue	lymphoid_neoplasm	lymphoplasmacytic_lymphoma	NS	Unknown	ENST00000618050.4	481	Q06187	481	cosmicV97nov2022
ALK_ENST00000642122	No	Alectinib	G134R	G	134	R	400G>A	G	A	lung	carcinoma	adenocarcinoma	NS	Unknown	ENST00000642122.1	134	Q9UM73	1202	cosmicV97nov2022
FGFR2_ENST00000358487	No	Pemigatinib	N549K	N	549	K	?	?	NA	biliary_tract	carcinoma	adenocarcinoma	NS	Unknown	ENST00000358487.9	549	P21802	549	cosmicV97nov2022
ABL1_ENST00000318560	No	Imatinib	T315I	T	315	I	944C>T	C	T	haematopoietic_and_lymphoid_tissue	lymphoid_neoplasm	acute_lymphoblastic_leukaemia	Ph_positive	Heterozygous	ENST00000318560.5	315	P00519	315	cosmicV97nov2022
ABL1_ENST00000318560	No	Imatinib	F317L	F	317	L	?	?	NA	haematopoietic_and_lymphoid_tissue	haematopoietic_neoplasm	blast_phase_chronic_myeloid_leukaemia	NS	Unknown	ENST00000318560.5	317	P00519	317	cosmicV97nov2022
ABL1_ENST00000318560	No	Imatinib	Y253H	Y	253	H	?	?	NA	haematopoietic_and_lymphoid_tissue	haematopoietic_neoplasm	blast_phase_chronic_myeloid_leukaemia	NS	Unknown	ENST00000318560.5	253	P00519	253	cosmicV97nov2022
EGFR	Yes	Erlotinib	T790M	T	790	M	2369C>T	C	T	lung	carcinoma	adenocarcinoma	NS	Unknown	ENST00000275493.6	790	P00533	790	cosmicV97nov2022
ALK_ENST00000642122	No	Crizotinib	F106V	F	106	V	316T>G	T	G	lung	carcinoma	mixed_adenosquamous_carcinoma	NS	Heterozygous	ENST00000642122.1	106	Q9UM73	1174	cosmicV97nov2022
MET_ENST00000397752	No	Savolitinib	D1228V	D	1228	V	3683A>T	A	T	lung	carcinoma	adenocarcinoma	NS	Unknown	ENST00000397752.7	1228	P08581	1228	cosmicV97nov2022
MET	Yes	Crizotinib	Y1248S	Y	1248	S	?	?	NA	lung	carcinoma	adenocarcinoma	NS	Unknown	ENST00000318493.10	1248	P08581	1230	cosmicV97nov2022
EGFR_ENST00000455089	No	Osimertinib	L747H	L	747	H	2240T>A	T	A	lung	carcinoma	non_small_cell_carcinoma	NS	Heterozygous	ENST00000455089.5	747	P00533	792	cosmicV97nov2022
EGFR_ENST00000454757	No	Osimertinib	L747R	L	747	R	2240T>G	T	G	lung	carcinoma	small_cell_carcinoma	NS	Unknown	ENST00000454757.6	747	P00533	792	cosmicV97nov2022
EGFR	Yes	Osimertinib	C797G	C	797	G	2389T>G	T	G	lung	carcinoma	adenocarcinoma	NS	Unknown	ENST00000275493.6	797	P00533	797	cosmicV97nov2022
EGFR_ENST00000454757	No	Osimertinib	L747V	L	747	V	2239C>G	C	G	lung	carcinoma	adenocarcinoma	NS	Unknown	ENST00000454757.6	747	P00533	792	cosmicV97nov2022
ERBB2_ENST00000445658	No	Trastuzumab	L593R	L	593	R	1778T>G	T	G	breast	carcinoma	ductal_carcinoma	NS	Unknown	ENST00000445658.6	593	P04626	869	cosmicV97nov2022
KIT	Yes	Imatinib	N822K	N	822	K	2466T>A	T	A	soft_tissue	gastrointestinal_stromal_tumour	spindle	NS	Heterozygous	ENST00000288135.5	822	P10721	822	cosmicV97nov2022
EGFR_ENST00000454757	No	Osimertinib	C752G	C	752	G	2254T>G	T	G	lung	carcinoma	adenocarcinoma	NS	Unknown	ENST00000454757.6	752	P00533	797	cosmicV97nov2022
FGFR2_ENST00000369060	No	Palbociclib	N433K	N	433	K	1299T>A	T	A	breast	carcinoma	ER-positive_carcinoma	NS	Unknown	ENST00000369060.8	433	P21802	549	cosmicV97nov2022
FGFR2_ENST00000358487	No	Debio1347	N549T	N	549	T	?	?	NA	biliary_tract	carcinoma	adenocarcinoma	NS	Unknown	ENST00000358487.9	549	P21802	549	cosmicV97nov2022
MAP2K2_ENST00000394867	No	Vemurafenib	C28S	C	28	S	82T>A	T	A	NS	malignant_melanoma	NS	NS	Unknown	ENST00000394867.8	28	P36507	125	cosmicV97nov2022
ERBB2_ENST00000584450	No	Trastuzumab	L869R	L	869	R	2606T>G	T	G	breast	carcinoma	ductal_carcinoma	NS	Unknown	ENST00000584450.5	869	P04626	869	cosmicV97nov2022
FGFR2_ENST00000356226	No	INCB054828	N432H	N	432	H	1294A>C	A	C	biliary_tract	carcinoma	adenocarcinoma	NS	Unknown	ENST00000356226.8	432	P21802	549	cosmicV97nov2022
ABL1_ENST00000318560	No	Imatinib	G250E	G	250	E	?	?	NA	haematopoietic_and_lymphoid_tissue	lymphoid_neoplasm	acute_lymphoblastic_leukaemia	NS	Unknown	ENST00000318560.5	250	P00519	250	cosmicV97nov2022
FLT3	Yes	Sorafenib	D835H	D	835	H	2503G>C	G	C	haematopoietic_and_lymphoid_tissue	haematopoietic_neoplasm	acute_myeloid_leukaemia_associated_with_MDS	NS	Heterozygous	ENST00000241453.11	835	P36888	835	cosmicV97nov2022
EGFR	Yes	Osimertinib	G796S	G	796	S	2386G>A	G	A	lung	carcinoma	adenocarcinoma	NS	Unknown	ENST00000275493.6	796	P00533	796	cosmicV97nov2022
MET	Yes	Crizotinib	Y1248H	Y	1248	H	3742T>C	T	C	lung	carcinoma	adenocarcinoma	NS	Unknown	ENST00000318493.10	1248	P08581	1230	cosmicV97nov2022
MET_ENST00000397752	No	Crizotinib	Y1230H	Y	1230	H	3688T>C	T	C	lung	carcinoma	adenocarcinoma	NS	Unknown	ENST00000397752.7	1230	P08581	1230	cosmicV97nov2022
FGFR4	Yes	Fisogatinib	V550M	V	550	M	1648G>A	G	A	liver	carcinoma	hepatocellular_carcinoma	NS	Unknown	ENST00000292408.8	550	P22455	550	cosmicV97nov2022
EGFR_ENST00000454757	No	Tyrosine kinase inhibitor - NS	T745M	T	745	M	2234C>T	C	T	lung	carcinoma	non_small_cell_carcinoma	NS	Unknown	ENST00000454757.6	745	P00533	790	cosmicV97nov2022
BTK	Yes	Ibrutinib	C515S	C	515	S	1543T>A	T	A	haematopoietic_and_lymphoid_tissue	lymphoid_neoplasm	chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma	NS	Unknown	ENST00000621635.4	515	Q06187	481	cosmicV97nov2022
EGFR_ENST00000454757	No	Osimertinib	G751S	G	751	S	2251G>A	G	A	lung	carcinoma	adenocarcinoma	NS	Unknown	ENST00000454757.6	751	P00533	796	cosmicV97nov2022
KIT	Yes	Imatinib	T670I	T	670	I	?	?	NA	soft_tissue	gastrointestinal_stromal_tumour	spindle	NS	Unknown	ENST00000288135.5	670	P10721	670	cosmicV97nov2022
FGFR2_ENST00000346997	No	INCB054828	N547H	N	547	H	1639A>C	A	C	biliary_tract	carcinoma	adenocarcinoma	NS	Unknown	ENST00000346997.6	547	P21802	549	cosmicV97nov2022
EGFR	Yes	Gefitinib	T790M	T	790	M	?	?	NA	lung	carcinoma	mixed_adenosquamous_carcinoma	NS	Unknown	ENST00000275493.6	790	P00533	790	cosmicV97nov2022
ALK_ENST00000618119	No	Alectinib	I794N	I	794	N	2381T>A	T	A	lung	carcinoma	non_small_cell_carcinoma	NS	Heterozygous	ENST00000618119.4	794	Q9UM73	1171	cosmicV97nov2022
KIT	Yes	Imatinib	K642E	K	642	E	?	?	NA	soft_tissue	gastrointestinal_stromal_tumour	NS	NS	Unknown	ENST00000288135.5	642	P10721	642	cosmicV97nov2022
BTK	Yes	Ibrutinib	C515S	C	515	S	1543T>A	T	A	haematopoietic_and_lymphoid_tissue	lymphoid_neoplasm	lymphoplasmacytic_lymphoma	NS	Unknown	ENST00000621635.4	515	Q06187	481	cosmicV97nov2022
BTK_ENST00000618050	No	Ibrutinib	C481S	C	481	S	1442G>C	G	C	haematopoietic_and_lymphoid_tissue	lymphoid_neoplasm	mantle_cell_lymphoma	NS	Unknown	ENST00000618050.4	481	Q06187	481	cosmicV97nov2022
FGFR4_ENST00000393637	No	Fisogatinib	V510M	V	510	M	1528G>A	G	A	liver	carcinoma	hepatocellular_carcinoma	NS	Unknown	ENST00000393637.5	510	P22455	550	cosmicV97nov2022
EGFR_ENST00000454757	No	Osimertinib	L747P	L	747	P	2240T>C	T	C	lung	carcinoma	adenocarcinoma	NS	Unknown	ENST00000454757.6	747	P00533	792	cosmicV97nov2022
KIT	Yes	Imatinib	N822K	N	822	K	2466T>A	T	A	soft_tissue	gastrointestinal_stromal_tumour	spindle	NS	Homozygous	ENST00000288135.5	822	P10721	822	cosmicV97nov2022
ALK_ENST00000618119	No	Crizotinib	F797V	F	797	V	2389T>G	T	G	lung	carcinoma	mixed_adenosquamous_carcinoma	NS	Heterozygous	ENST00000618119.4	797	Q9UM73	1174	cosmicV97nov2022
MAP2K2	Yes	Dabrafenib	C125S	C	125	S	374G>C	G	C	skin	malignant_melanoma	NS	NS	Unknown	ENST00000262948.9	125	P36507	125	cosmicV97nov2022
FLT3	Yes	Sorafenib	D835Y	D	835	Y	2503G>T	G	T	haematopoietic_and_lymphoid_tissue	haematopoietic_neoplasm	acute_myeloid_leukaemia	NS	Heterozygous	ENST00000241453.11	835	P36888	835	cosmicV97nov2022
BTK_ENST00000618050	No	Ibrutinib	C481S	C	481	S	1442G>C	G	C	haematopoietic_and_lymphoid_tissue	lymphoid_neoplasm	chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma	NS	Homozygous	ENST00000618050.4	481	Q06187	481	cosmicV97nov2022
FGFR4_ENST00000502906	No	Fisogatinib	V550L	V	550	L	1648G>C	G	C	liver	carcinoma	hepatocellular_carcinoma	NS	Unknown	ENST00000502906.5	550	P22455	550	cosmicV97nov2022
EGFR_ENST00000455089	No	Erlotinib	T745M	T	745	M	2234C>T	C	T	lung	carcinoma	non_small_cell_carcinoma	NS	Heterozygous	ENST00000455089.5	745	P00533	790	cosmicV97nov2022
FGFR2_ENST00000369056	No	BGJ398	L618M	L	618	M	1852T>A	T	A	biliary_tract	carcinoma	adenocarcinoma	NS	Unknown	ENST00000369056.5	618	P21802	617	cosmicV97nov2022
MAP2K2	Yes	Dabrafenib	N126D	N	126	D	376A>G	A	G	NS	malignant_melanoma	NS	NS	Unknown	ENST00000262948.9	126	P36507	126	cosmicV97nov2022
ERBB2	Yes	Trastuzumab	L869R	L	869	R	2606T>G	T	G	breast	carcinoma	ductal_carcinoma	NS	Unknown	ENST00000269571.9	869	P04626	869	cosmicV97nov2022
FGFR2	Yes	INCB054828	N550H	N	550	H	1648A>C	A	C	biliary_tract	carcinoma	adenocarcinoma	NS	Unknown	ENST00000457416.6	550	P21802	549	cosmicV97nov2022
ABL1_ENST00000318560	No	Tyrosine kinase inhibitor - NS	D276G	D	276	G	827A>G	A	G	haematopoietic_and_lymphoid_tissue	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	Unknown	ENST00000318560.5	276	P00519	276	cosmicV97nov2022
KIT	Yes	Nilotinib	N655T	N	655	T	?	?	NA	soft_tissue	gastrointestinal_stromal_tumour	spindle	NS	Unknown	ENST00000288135.5	655	P10721	655	cosmicV97nov2022
BTK	Yes	Ibrutinib	C515R	C	515	R	1543T>C	T	C	haematopoietic_and_lymphoid_tissue	lymphoid_neoplasm	lymphoplasmacytic_lymphoma	NS	Unknown	ENST00000621635.4	515	Q06187	481	cosmicV97nov2022
EGFR_ENST00000455089	No	Osimertinib	L673Q	L	673	Q	2018T>A	T	A	lung	carcinoma	adenocarcinoma	NS	Homozygous	ENST00000455089.5	673	P00533	718	cosmicV97nov2022
MET_ENST00000397752	No	Capmatinib	D1228N	D	1228	N	3682G>A	G	A	lung	carcinoma	adenocarcinoma	NS	Unknown	ENST00000397752.7	1228	P08581	1228	cosmicV97nov2022
FGFR1_ENST00000397113	No	Palbociclib	N544K	N	544	K	1632C>A	C	A	breast	carcinoma	ER-positive_carcinoma	NS	Unknown	ENST00000397113.6	544	P11362	546	cosmicV97nov2022
FGFR2_ENST00000358487	No	Pemigatinib	K641R	K	641	R	?	?	NA	biliary_tract	carcinoma	adenocarcinoma	NS	Unknown	ENST00000358487.9	641	P21802	641	cosmicV97nov2022
ERBB2_ENST00000584601	No	Trastuzumab	L839R	L	839	R	2516T>G	T	G	breast	carcinoma	ductal_carcinoma	NS	Unknown	ENST00000584601.5	839	P04626	869	cosmicV97nov2022
ABL1_ENST00000318560	No	Dasatinib	F317L	F	317	L	?	?	NA	haematopoietic_and_lymphoid_tissue	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	Unknown	ENST00000318560.5	317	P00519	317	cosmicV97nov2022
EGFR	Yes	Erlotinib	T790M	T	790	M	?	?	NA	lung	carcinoma	adenocarcinoma	transformed_to_small_cell_carcinoma	Unknown	ENST00000275493.6	790	P00533	790	cosmicV97nov2022
BTK	Yes	Ibrutinib	C515Y	C	515	Y	1544G>A	G	A	haematopoietic_and_lymphoid_tissue	lymphoid_neoplasm	lymphoplasmacytic_lymphoma	NS	Unknown	ENST00000621635.4	515	Q06187	481	cosmicV97nov2022
EGFR_ENST00000455089	No	Osimertinib	L702P	L	702	P	2104_2105delinsCC	C	NA	lung	carcinoma	adenocarcinoma	NS	Unknown	ENST00000455089.5	702	P00533	747	cosmicV97nov2022
BTK_ENST00000308731	No	Ibrutinib	C481S	C	481	S	1441T>A	T	A	haematopoietic_and_lymphoid_tissue	lymphoid_neoplasm	chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma	NS	Unknown	ENST00000308731.7	481	Q06187	481	cosmicV97nov2022
BTK	Yes	Ibrutinib	C515S	C	515	S	1544G>C	G	C	haematopoietic_and_lymphoid_tissue	lymphoid_neoplasm	chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma	Richter_transformation	Unknown	ENST00000621635.4	515	Q06187	481	cosmicV97nov2022
EGFR	Yes	Osimertinib	L792F	L	792	F	2374C>T	C	T	lung	carcinoma	non_small_cell_carcinoma	NS	Heterozygous	ENST00000275493.6	792	P00533	792	cosmicV97nov2022
ALK_ENST00000618119	No	Alectinib	G825R	G	825	R	2473G>A	G	A	lung	carcinoma	adenocarcinoma	NS	Unknown	ENST00000618119.4	825	Q9UM73	1202	cosmicV97nov2022
EGFR_ENST00000455089	No	Gefitinib	D716Y	D	716	Y	2146G>T	G	T	lung	carcinoma	adenocarcinoma	NS	Heterozygous	ENST00000455089.5	716	P00533	761	cosmicV97nov2022
ABL1_ENST00000318560	No	Imatinib	E255K	E	255	K	?	?	NA	haematopoietic_and_lymphoid_tissue	lymphoid_neoplasm	acute_lymphoblastic_leukaemia	NS	Unknown	ENST00000318560.5	255	P00519	255	cosmicV97nov2022
ABL1_ENST00000318560	No	Nilotinib	G250E	G	250	E	?	?	NA	haematopoietic_and_lymphoid_tissue	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	Unknown	ENST00000318560.5	250	P00519	250	cosmicV97nov2022
ALK_ENST00000642122	No	Crizotinib	C88Y	C	88	Y	263G>A	G	A	lung	carcinoma	non_small_cell_carcinoma	NS	Unknown	ENST00000642122.1	88	Q9UM73	1156	cosmicV97nov2022
ALK_ENST00000618119	No	Crizotinib	G825R	G	825	R	2473G>A	G	A	lung	carcinoma	adenocarcinoma	NS	Heterozygous	ENST00000618119.4	825	Q9UM73	1202	cosmicV97nov2022
KIT	Yes	Imatinib	N822Y	N	822	Y	2464A>T	A	T	soft_tissue	gastrointestinal_stromal_tumour	spindle	NS	Unknown	ENST00000288135.5	822	P10721	822	cosmicV97nov2022
BRAF_ENST00000496384	No	Vemurafenib	L505H	L	505	H	1514T>A	T	A	skin	malignant_melanoma	NS	NS	Unknown	ENST00000496384.7	505	P15056	505	cosmicV97nov2022
BTK	Yes	Acalabrutinib	C515S	C	515	S	1544G>C	G	C	haematopoietic_and_lymphoid_tissue	lymphoid_neoplasm	chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma	Richter_transformation	Unknown	ENST00000621635.4	515	Q06187	481	cosmicV97nov2022
EGFR_ENST00000455089	No	Osimertinib	C752S	C	752	S	2254T>A	T	A	lung	carcinoma	non_small_cell_carcinoma	NS	Heterozygous	ENST00000455089.5	752	P00533	797	cosmicV97nov2022
FGFR2_ENST00000358487	No	Palbociclib	N549K	N	549	K	1647T>A	T	A	breast	carcinoma	ER-positive_carcinoma	NS	Unknown	ENST00000358487.9	549	P21802	549	cosmicV97nov2022
FGFR2_ENST00000358487	No	Debio1347	L617V	L	617	V	?	?	NA	biliary_tract	carcinoma	adenocarcinoma	NS	Unknown	ENST00000358487.9	617	P21802	617	cosmicV97nov2022
KIT	Yes	Imatinib	V654A	V	654	A	?	?	NA	soft_tissue	gastrointestinal_stromal_tumour	spindle	NS	Unknown	ENST00000288135.5	654	P10721	654	cosmicV97nov2022
ALK	Yes	Brigatinib	G1202R	G	1202	R	?	?	NA	lung	carcinoma	non_small_cell_carcinoma	NS	Unknown	ENST00000389048.7	1202	Q9UM73	1202	cosmicV97nov2022
KIT	Yes	Imatinib	N822K	N	822	K	2466T>G	T	G	soft_tissue	gastrointestinal_stromal_tumour	NS	NS	Unknown	ENST00000288135.5	822	P10721	822	cosmicV97nov2022
ALK_ENST00000618119	No	Crizotinib	C779Y	C	779	Y	2336G>A	G	A	lung	carcinoma	non_small_cell_carcinoma	NS	Unknown	ENST00000618119.4	779	Q9UM73	1156	cosmicV97nov2022
MAP2K1	Yes	Dabrafenib	G128D	G	128	D	383G>A	G	A	skin	malignant_melanoma	NS	NS	Heterozygous	ENST00000307102.9	128	Q02750	128	cosmicV97nov2022
MET_ENST00000397752	No	Crizotinib	D1228N	D	1228	N	3682G>A	G	A	lung	carcinoma	squamous_cell_carcinoma	NS	Unknown	ENST00000397752.7	1228	P08581	1228	cosmicV97nov2022
EGFR_ENST00000454757	No	Osimertinib	L702P	L	702	P	2104_2105delinsCC	C	NA	lung	carcinoma	adenocarcinoma	NS	Unknown	ENST00000454757.6	702	P00533	747	cosmicV97nov2022
ALK	Yes	Brigatinib	L1196M	L	1196	M	?	?	NA	lung	carcinoma	non_small_cell_carcinoma	NS	Unknown	ENST00000389048.7	1196	Q9UM73	1196	cosmicV97nov2022
EGFR_ENST00000455089	No	Osimertinib	C752S	C	752	S	2255G>C	G	C	lung	carcinoma	small_cell_carcinoma	NS	Unknown	ENST00000455089.5	752	P00533	797	cosmicV97nov2022
MAP2K1	Yes	Dabrafenib	P124S	P	124	S	370C>T	C	T	NS	malignant_melanoma	NS	NS	Unknown	ENST00000307102.9	124	Q02750	124	cosmicV97nov2022
ABL1	Yes	Imatinib	D295G	D	295	G	884A>G	A	G	haematopoietic_and_lymphoid_tissue	lymphoid_neoplasm	acute_lymphoblastic_leukaemia	Ph_positive	Unknown	ENST00000372348.6	295	P00519	276	cosmicV97nov2022
EGFR_ENST00000455089	No	Erlotinib	T745M	T	745	M	2234C>T	C	T	lung	carcinoma	adenocarcinoma	NS	Heterozygous	ENST00000455089.5	745	P00533	790	cosmicV97nov2022
FGFR4_ENST00000393637	No	Fisogatinib	V510L	V	510	L	1528G>C	G	C	liver	carcinoma	hepatocellular_carcinoma	NS	Unknown	ENST00000393637.5	510	P22455	550	cosmicV97nov2022
PDGFRA	Yes	Crenolanib	D842V	D	842	V	2525A>T	A	T	soft_tissue	gastrointestinal_stromal_tumour	epithelioid	NS	Heterozygous	ENST00000257290.9	842	P16234	842	cosmicV97nov2022
FGFR2_ENST00000346997	No	Palbociclib	N547K	N	547	K	1641T>A	T	A	breast	carcinoma	ER-positive_carcinoma	NS	Unknown	ENST00000346997.6	547	P21802	549	cosmicV97nov2022
FGFR2_ENST00000358487	No	Pemigatinib	E565A	E	565	A	?	?	NA	biliary_tract	carcinoma	adenocarcinoma	NS	Unknown	ENST00000358487.9	565	P21802	565	cosmicV97nov2022
MAP2K2	Yes	Vemurafenib	C125S	C	125	S	373T>A	T	A	NS	malignant_melanoma	NS	NS	Unknown	ENST00000262948.9	125	P36507	125	cosmicV97nov2022
KIT	Yes	Imatinib	V654A	V	654	A	?	?	NA	soft_tissue	gastrointestinal_stromal_tumour	epithelioid	NS	Unknown	ENST00000288135.5	654	P10721	654	cosmicV97nov2022
EGFR	Yes	Gefitinib	T790M	T	790	M	2369C>T	C	T	lung	carcinoma	bronchioloalveolar_adenocarcinoma	NS	Unknown	ENST00000275493.6	790	P00533	790	cosmicV97nov2022
ABL1_ENST00000318560	No	Imatinib	T315I	T	315	I	944C>T	C	T	haematopoietic_and_lymphoid_tissue	haematopoietic_neoplasm	chronic_myeloid_leukaemia	Ph_positive	Heterozygous	ENST00000318560.5	315	P00519	315	cosmicV97nov2022
ALK_ENST00000642122	No	Crizotinib	G134R	G	134	R	400G>A	G	A	lung	carcinoma	adenocarcinoma	NS	Heterozygous	ENST00000642122.1	134	Q9UM73	1202	cosmicV97nov2022
BRAF_ENST00000288602	No	Vemurafenib	L545H	L	545	H	1634T>A	T	A	skin	malignant_melanoma	NS	NS	Unknown	ENST00000288602.11	545	P15056	505	cosmicV97nov2022
EGFR_ENST00000455089	No	Osimertinib	G751S	G	751	S	2251G>A	G	A	lung	carcinoma	adenocarcinoma	NS	Unknown	ENST00000455089.5	751	P00533	796	cosmicV97nov2022
FGFR2_ENST00000358487	No	BGJ398	N549H	N	549	H	?	?	NA	biliary_tract	carcinoma	adenocarcinoma	NS	Unknown	ENST00000358487.9	549	P21802	549	cosmicV97nov2022
FGFR4_ENST00000502906	No	Fisogatinib	V550L	V	550	L	1648G>T	G	T	liver	carcinoma	hepatocellular_carcinoma	NS	Unknown	ENST00000502906.5	550	P22455	550	cosmicV97nov2022
BTK_ENST00000308731	No	Ibrutinib	C481S	C	481	S	1441T>A	T	A	haematopoietic_and_lymphoid_tissue	lymphoid_neoplasm	chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma	Richter_transformation	Unknown	ENST00000308731.7	481	Q06187	481	cosmicV97nov2022
FGFR1	Yes	Palbociclib	N577K	N	577	K	1731C>A	C	A	breast	carcinoma	ER-positive_carcinoma	NS	Unknown	ENST00000425967.7	577	P11362	546	cosmicV97nov2022
FGFR1_ENST00000397103	No	Palbociclib	N457K	N	457	K	1371C>A	C	A	breast	carcinoma	ER-positive_carcinoma	NS	Unknown	ENST00000397103.5	457	P11362	546	cosmicV97nov2022
FGFR2_ENST00000360144	No	Palbociclib	N461K	N	461	K	1383T>A	T	A	breast	carcinoma	ER-positive_carcinoma	NS	Unknown	ENST00000360144.7	461	P21802	549	cosmicV97nov2022
FGFR2_ENST00000356226	No	BGJ398	E448A	E	448	A	1343A>C	A	C	biliary_tract	carcinoma	adenocarcinoma	NS	Unknown	ENST00000356226.8	448	P21802	565	cosmicV97nov2022
KIT	Yes	Sunitinib	N822K	N	822	K	2466T>G	T	G	soft_tissue	gastrointestinal_stromal_tumour	NS	NS	Heterozygous	ENST00000288135.5	822	P10721	822	cosmicV97nov2022
EGFR_ENST00000454757	No	Tyrosine kinase inhibitor - NS	T745M	T	745	M	2234C>T	C	T	lung	carcinoma	adenocarcinoma	NS	Unknown	ENST00000454757.6	745	P00533	790	cosmicV97nov2022
EGFR	Yes	Erlotinib	T790M	T	790	M	?	?	NA	lung	carcinoma	adenocarcinoma	NS	Heterozygous	ENST00000275493.6	790	P00533	790	cosmicV97nov2022
EGFR	Yes	Gefitinib	T790M	T	790	M	?	?	NA	lung	carcinoma	adenocarcinoma	transformed_to_small_cell_carcinoma	Unknown	ENST00000275493.6	790	P00533	790	cosmicV97nov2022
BTK_ENST00000308731	No	Ibrutinib	C481S	C	481	S	1442G>C	G	C	haematopoietic_and_lymphoid_tissue	lymphoid_neoplasm	chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma	NS	Homozygous	ENST00000308731.7	481	Q06187	481	cosmicV97nov2022
MET	Yes	Crizotinib	D1246N	D	1246	N	3736G>A	G	A	lung	carcinoma	adenocarcinoma	NS	Unknown	ENST00000318493.10	1246	P08581	1228	cosmicV97nov2022
EGFR_ENST00000455089	No	Osimertinib	L747V	L	747	V	2239C>G	C	G	lung	carcinoma	adenocarcinoma	NS	Unknown	ENST00000455089.5	747	P00533	792	cosmicV97nov2022
PDGFRA	Yes	Imatinib	D842V	D	842	V	?	?	NA	soft_tissue	gastrointestinal_stromal_tumour	epithelioid	NS	Heterozygous	ENST00000257290.9	842	P16234	842	cosmicV97nov2022
EGFR_ENST00000454757	No	Gefitinib	D716Y	D	716	Y	2146G>T	G	T	lung	carcinoma	adenocarcinoma	NS	Heterozygous	ENST00000454757.6	716	P00533	761	cosmicV97nov2022
KIT	Yes	Imatinib	V654A	V	654	A	1961T>C	T	C	soft_tissue	gastrointestinal_stromal_tumour	NS	NS	Heterozygous	ENST00000288135.5	654	P10721	654	cosmicV97nov2022
ABL1_ENST00000318560	No	Nilotinib	E255K	E	255	K	?	?	NA	haematopoietic_and_lymphoid_tissue	haematopoietic_neoplasm	blast_phase_chronic_myeloid_leukaemia	NS	Unknown	ENST00000318560.5	255	P00519	255	cosmicV97nov2022
EGFR	Yes	Erlotinib	T790M	T	790	M	2369C>T	C	T	lung	carcinoma	adenocarcinoma	NS	Heterozygous	ENST00000275493.6	790	P00533	790	cosmicV97nov2022
BTK	Yes	Ibrutinib	C515S	C	515	S	1544G>C	G	C	haematopoietic_and_lymphoid_tissue	lymphoid_neoplasm	chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma	NS	Homozygous	ENST00000621635.4	515	Q06187	481	cosmicV97nov2022
FGFR2_ENST00000369056	No	INCB054828	N550H	N	550	H	1648A>C	A	C	biliary_tract	carcinoma	adenocarcinoma	NS	Unknown	ENST00000369056.5	550	P21802	549	cosmicV97nov2022
EGFR	Yes	Tyrosine kinase inhibitor - NS	T790M	T	790	M	2369C>T	C	T	lung	carcinoma	non_small_cell_carcinoma	NS	Unknown	ENST00000275493.6	790	P00533	790	cosmicV97nov2022
ALK	Yes	Crizotinib	G1202R	G	1202	R	3604G>A	G	A	lung	carcinoma	adenocarcinoma	NS	Unknown	ENST00000389048.7	1202	Q9UM73	1202	cosmicV97nov2022
BTK	Yes	Acalabrutinib	C515S	C	515	S	1544G>C	G	C	haematopoietic_and_lymphoid_tissue	lymphoid_neoplasm	chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma	NS	Unknown	ENST00000621635.4	515	Q06187	481	cosmicV97nov2022
BTK_ENST00000618050	No	Ibrutinib	C481R	C	481	R	1441T>C	T	C	haematopoietic_and_lymphoid_tissue	lymphoid_neoplasm	chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma	NS	Unknown	ENST00000618050.4	481	Q06187	481	cosmicV97nov2022
EGFR_ENST00000455089	No	Osimertinib	L673Q	L	673	Q	2018T>A	T	A	lung	carcinoma	non_small_cell_carcinoma	NS	Unknown	ENST00000455089.5	673	P00533	718	cosmicV97nov2022
FGFR2_ENST00000351936	No	BGJ398	L617M	L	617	M	1849T>A	T	A	biliary_tract	carcinoma	adenocarcinoma	NS	Unknown	ENST00000351936.10	617	P21802	617	cosmicV97nov2022
FGFR2_ENST00000360144	No	BGJ398	L529M	L	529	M	1585T>A	T	A	biliary_tract	carcinoma	adenocarcinoma	NS	Unknown	ENST00000360144.7	529	P21802	617	cosmicV97nov2022
EGFR_ENST00000454757	No	Tyrosine kinase inhibitor - NS	T745M	T	745	M	2234C>T	C	T	lung	carcinoma	adenocarcinoma	NS	Heterozygous	ENST00000454757.6	745	P00533	790	cosmicV97nov2022
EGFR_ENST00000454757	No	Osimertinib	L673Q	L	673	Q	2018T>A	T	A	lung	carcinoma	adenocarcinoma	NS	Homozygous	ENST00000454757.6	673	P00533	718	cosmicV97nov2022
MET	Yes	Capmatinib	Y1248H	Y	1248	H	3742T>C	T	C	lung	carcinoma	adenocarcinoma	NS	Unknown	ENST00000318493.10	1248	P08581	1230	cosmicV97nov2022
FGFR2_ENST00000369056	No	BGJ398	E566A	E	566	A	1697A>C	A	C	biliary_tract	carcinoma	adenocarcinoma	NS	Unknown	ENST00000369056.5	566	P21802	565	cosmicV97nov2022
KDR_ENST00000263923	No	Cetuximab	L840F	L	840	F	2518C>T	C	T	large_intestine	carcinoma	adenocarcinoma	NS	Heterozygous	ENST00000263923.5	840	P35968	840	cosmicV97nov2022
KIT	Yes	Imatinib	N822Y	N	822	Y	2464A>T	A	T	soft_tissue	gastrointestinal_stromal_tumour	epithelioid	NS	Unknown	ENST00000288135.5	822	P10721	822	cosmicV97nov2022
EGFR	Yes	Gefitinib	T790M	T	790	M	?	?	NA	lung	carcinoma	adenocarcinoma	transformed_to_squamous_cell_carcinoma	Unknown	ENST00000275493.6	790	P00533	790	cosmicV97nov2022
MAP2K1	Yes	Vemurafenib	E203K	E	203	K	?	?	NA	skin	malignant_melanoma	NS	NS	Unknown	ENST00000307102.9	203	Q02750	203	cosmicV97nov2022
KIT	Yes	Imatinib	V654A	V	654	A	1961T>C	T	C	soft_tissue	gastrointestinal_stromal_tumour	transdifferentiated	rhabdomyoblastic_and_anaplastic	Heterozygous	ENST00000288135.5	654	P10721	654	cosmicV97nov2022
MET	Yes	Crizotinib	Y1248H	Y	1248	H	?	?	NA	lung	carcinoma	adenocarcinoma	NS	Unknown	ENST00000318493.10	1248	P08581	1230	cosmicV97nov2022
ALK_ENST00000618119	No	Crizotinib	L819M	L	819	M	2455C>A	C	A	lung	carcinoma	adenocarcinoma	NS	Homozygous	ENST00000618119.4	819	Q9UM73	1196	cosmicV97nov2022
EGFR_ENST00000454757	No	Gefitinib	T745M	T	745	M	2234C>T	C	T	lung	carcinoma	squamous_cell_carcinoma	NS	Unknown	ENST00000454757.6	745	P00533	790	cosmicV97nov2022
MAP2K2_ENST00000394867	No	Dabrafenib	C28S	C	28	S	83G>C	G	C	skin	malignant_melanoma	NS	NS	Unknown	ENST00000394867.8	28	P36507	125	cosmicV97nov2022
MAP2K2_ENST00000394867	No	Dabrafenib	E110K	E	110	K	328G>A	G	A	skin	malignant_melanoma	NS	NS	Heterozygous	ENST00000394867.8	110	P36507	207	cosmicV97nov2022
FLT3	Yes	Sorafenib	F691L	F	691	L	2073T>G	T	G	haematopoietic_and_lymphoid_tissue	haematopoietic_neoplasm	acute_myeloid_leukaemia	NS	Heterozygous	ENST00000241453.11	691	P36888	691	cosmicV97nov2022
EGFR_ENST00000455089	No	Tyrosine kinase inhibitor - NS	T745M	T	745	M	2234C>T	C	T	lung	carcinoma	non_small_cell_carcinoma	NS	Unknown	ENST00000455089.5	745	P00533	790	cosmicV97nov2022
EGFR_ENST00000455089	No	Osimertinib	L747R	L	747	R	2240T>G	T	G	lung	carcinoma	small_cell_carcinoma	NS	Unknown	ENST00000455089.5	747	P00533	792	cosmicV97nov2022
EGFR_ENST00000455089	No	Osimertinib	G751R	G	751	R	2251G>C	G	C	lung	carcinoma	adenocarcinoma	NS	Unknown	ENST00000455089.5	751	P00533	796	cosmicV97nov2022
EGFR	Yes	Gefitinib	D761Y	D	761	Y	2281G>T	G	T	lung	carcinoma	adenocarcinoma	NS	Heterozygous	ENST00000275493.6	761	P00533	761	cosmicV97nov2022
EGFR	Yes	Gefitinib	T790M	T	790	M	?	?	NA	lung	carcinoma	acinar_adenocarcinoma	NS	Unknown	ENST00000275493.6	790	P00533	790	cosmicV97nov2022
EGFR	Yes	Osimertinib	L718V	L	718	V	2152C>G	C	G	lung	carcinoma	adenocarcinoma	NS	Unknown	ENST00000275493.6	718	P00533	718	cosmicV97nov2022
FGFR2_ENST00000358487	No	Pemigatinib	L617V	L	617	V	?	?	NA	biliary_tract	carcinoma	adenocarcinoma	NS	Unknown	ENST00000358487.9	617	P21802	617	cosmicV97nov2022
ABL1_ENST00000318560	No	Tyrosine kinase inhibitor - NS	F317L	F	317	L	?	?	NA	haematopoietic_and_lymphoid_tissue	haematopoietic_neoplasm	blast_phase_chronic_myeloid_leukaemia	NS	Unknown	ENST00000318560.5	317	P00519	317	cosmicV97nov2022
MET	Yes	Savolitinib	D1246V	D	1246	V	3737A>T	A	T	lung	carcinoma	adenocarcinoma	NS	Unknown	ENST00000318493.10	1246	P08581	1228	cosmicV97nov2022
BTK	Yes	Ibrutinib	C515S	C	515	S	1544G>C	G	C	haematopoietic_and_lymphoid_tissue	lymphoid_neoplasm	chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma	NS	Heterozygous	ENST00000621635.4	515	Q06187	481	cosmicV97nov2022
FLT3	Yes	Sorafenib	D835Y	D	835	Y	?	?	NA	haematopoietic_and_lymphoid_tissue	haematopoietic_neoplasm	acute_myeloid_leukaemia	NS	Unknown	ENST00000241453.11	835	P36888	835	cosmicV97nov2022
ALK_ENST00000618119	No	Crizotinib	G825R	G	825	R	2473G>A	G	A	lung	carcinoma	adenocarcinoma	NS	Unknown	ENST00000618119.4	825	Q9UM73	1202	cosmicV97nov2022
ALK_ENST00000618119	No	Crizotinib	L819M	L	819	M	2455C>A	C	A	lung	carcinoma	adenocarcinoma	NS	Unknown	ENST00000618119.4	819	Q9UM73	1196	cosmicV97nov2022
BTK_ENST00000308731	No	Acalabrutinib	C481S	C	481	S	1442G>C	G	C	haematopoietic_and_lymphoid_tissue	lymphoid_neoplasm	chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma	NS	Unknown	ENST00000308731.7	481	Q06187	481	cosmicV97nov2022
BTK_ENST00000308731	No	Ibrutinib	C481S	C	481	S	1442G>C	G	C	haematopoietic_and_lymphoid_tissue	lymphoid_neoplasm	chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma	Richter_transformation	Unknown	ENST00000308731.7	481	Q06187	481	cosmicV97nov2022
FGFR2_ENST00000478859	No	BGJ398	L389M	L	389	M	1165T>A	T	A	biliary_tract	carcinoma	adenocarcinoma	NS	Unknown	ENST00000478859.5	389	P21802	617	cosmicV97nov2022
PDGFRA	Yes	Imatinib	D842V	D	842	V	?	?	NA	soft_tissue	gastrointestinal_stromal_tumour	epithelioid	NS	Unknown	ENST00000257290.9	842	P16234	842	cosmicV97nov2022
ABL1_ENST00000318560	No	Nilotinib	Y253H	Y	253	H	?	?	NA	haematopoietic_and_lymphoid_tissue	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	Unknown	ENST00000318560.5	253	P00519	253	cosmicV97nov2022
ALK	Yes	Alectinib	I1171N	I	1171	N	3512T>A	T	A	lung	carcinoma	non_small_cell_carcinoma	NS	Heterozygous	ENST00000389048.7	1171	Q9UM73	1171	cosmicV97nov2022
FLT3	Yes	Sunitinib	D835Y	D	835	Y	2503G>T	G	T	haematopoietic_and_lymphoid_tissue	haematopoietic_neoplasm	acute_myeloid_leukaemia	NS	Heterozygous	ENST00000241453.11	835	P36888	835	cosmicV97nov2022
FGFR2_ENST00000358487	No	BGJ398	E565A	E	565	A	?	?	NA	biliary_tract	carcinoma	adenocarcinoma	NS	Unknown	ENST00000358487.9	565	P21802	565	cosmicV97nov2022
BTK_ENST00000308731	No	Ibrutinib	C481R	C	481	R	1441T>C	T	C	haematopoietic_and_lymphoid_tissue	lymphoid_neoplasm	chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma	NS	Unknown	ENST00000308731.7	481	Q06187	481	cosmicV97nov2022
FGFR2_ENST00000613048	No	INCB054828	N460H	N	460	H	1378A>C	A	C	biliary_tract	carcinoma	adenocarcinoma	NS	Unknown	ENST00000613048.4	460	P21802	549	cosmicV97nov2022
ABL1_ENST00000318560	No	Imatinib	F311I	F	311	I	?	?	NA	haematopoietic_and_lymphoid_tissue	haematopoietic_neoplasm	blast_phase_chronic_myeloid_leukaemia	NS	Unknown	ENST00000318560.5	311	P00519	311	cosmicV97nov2022
KIT	Yes	Imatinib	D820G	D	820	G	?	?	NA	soft_tissue	gastrointestinal_stromal_tumour	spindle_and_epithelioid	NS	Unknown	ENST00000288135.5	820	P10721	820	cosmicV97nov2022
ALK	Yes	Crizotinib	C1156Y	C	1156	Y	3467G>A	G	A	lung	carcinoma	adenocarcinoma	NS	Heterozygous	ENST00000389048.7	1156	Q9UM73	1156	cosmicV97nov2022
FLT3	Yes	Quizartinib	F691L	F	691	L	2073T>G	T	G	haematopoietic_and_lymphoid_tissue	haematopoietic_neoplasm	acute_myeloid_leukaemia	NS	Heterozygous	ENST00000241453.11	691	P36888	691	cosmicV97nov2022
EGFR_ENST00000455089	No	Osimertinib	L747F	L	747	F	2239C>T	C	T	lung	carcinoma	non_small_cell_carcinoma	NS	Heterozygous	ENST00000455089.5	747	P00533	792	cosmicV97nov2022
EGFR_ENST00000454757	No	Osimertinib	L747R	L	747	R	2240T>G	T	G	lung	carcinoma	adenocarcinoma	NS	Unknown	ENST00000454757.6	747	P00533	792	cosmicV97nov2022
FGFR2_ENST00000369060	No	BGJ398	L501M	L	501	M	1501T>A	T	A	biliary_tract	carcinoma	adenocarcinoma	NS	Unknown	ENST00000369060.8	501	P21802	617	cosmicV97nov2022
EGFR	Yes	Erlotinib	T790M	T	790	M	2369C>T	C	T	lung	carcinoma	bronchioloalveolar_adenocarcinoma	NS	Unknown	ENST00000275493.6	790	P00533	790	cosmicV97nov2022
ERBB2_ENST00000541774	No	Trastuzumab	L854R	L	854	R	2561T>G	T	G	breast	carcinoma	ductal_carcinoma	NS	Unknown	ENST00000541774.5	854	P04626	869	cosmicV97nov2022
FGFR2_ENST00000358487	No	INCB054828	N549H	N	549	H	1645A>C	A	C	biliary_tract	carcinoma	adenocarcinoma	NS	Unknown	ENST00000358487.9	549	P21802	549	cosmicV97nov2022
ALK_ENST00000642122	No	Crizotinib	F106L	F	106	L	318C>G	C	G	soft_tissue	inflammatory_myofibroblastic_tumour	NS	NS	Homozygous	ENST00000642122.1	106	Q9UM73	1174	cosmicV97nov2022
ALK_ENST00000642122	No	Crizotinib	C88Y	C	88	Y	263G>A	G	A	lung	carcinoma	adenocarcinoma	NS	Heterozygous	ENST00000642122.1	88	Q9UM73	1156	cosmicV97nov2022
KIT	Yes	Imatinib	V654A	V	654	A	?	?	NA	soft_tissue	gastrointestinal_stromal_tumour	dedifferentiated	anaplastic_and_spindle_and_epithelioid	Unknown	ENST00000288135.5	654	P10721	654	cosmicV97nov2022
KIT	Yes	Imatinib	D820Y	D	820	Y	?	?	NA	soft_tissue	gastrointestinal_stromal_tumour	spindle_and_epithelioid	NS	Unknown	ENST00000288135.5	820	P10721	820	cosmicV97nov2022
EGFR	Yes	Icotinib	T790M	T	790	M	?	?	NA	lung	carcinoma	hepatoid_adenocarcinoma	NS	Unknown	ENST00000275493.6	790	P00533	790	cosmicV97nov2022
MET	Yes	Crizotinib	D1246N	D	1246	N	?	?	NA	lung	carcinoma	sarcomatoid_carcinoma	NS	Unknown	ENST00000318493.10	1246	P08581	1228	cosmicV97nov2022
EGFR_ENST00000455089	No	Erlotinib	T745M	T	745	M	2234C>T	C	T	lung	carcinoma	bronchioloalveolar_adenocarcinoma	NS	Unknown	ENST00000455089.5	745	P00533	790	cosmicV97nov2022
ALK	Yes	Crizotinib	L1196M	L	1196	M	3586C>A	C	A	lung	carcinoma	adenocarcinoma	NS	Homozygous	ENST00000389048.7	1196	Q9UM73	1196	cosmicV97nov2022
EGFR	Yes	Osimertinib	T790M	T	790	M	?	?	NA	lung	carcinoma	adenocarcinoma	transformed_to_sarcomatoid_carcinoma	Unknown	ENST00000275493.6	790	P00533	790	cosmicV97nov2022
FGFR2_ENST00000369061	No	Palbociclib	N437K	N	437	K	1311T>A	T	A	breast	carcinoma	ER-positive_carcinoma	NS	Unknown	ENST00000369061.8	437	P21802	549	cosmicV97nov2022
ALK	Yes	Crizotinib	G1202R	G	1202	R	3604G>A	G	A	lung	carcinoma	adenocarcinoma	NS	Heterozygous	ENST00000389048.7	1202	Q9UM73	1202	cosmicV97nov2022
EGFR_ENST00000455089	No	Afatinib	T745M	T	745	M	2234C>T	C	T	lung	carcinoma	bronchioloalveolar_adenocarcinoma	NS	Unknown	ENST00000455089.5	745	P00533	790	cosmicV97nov2022
FGFR4_ENST00000393648	No	Fisogatinib	V482L	V	482	L	1444G>C	G	C	liver	carcinoma	hepatocellular_carcinoma	NS	Unknown	ENST00000393648.6	482	P22455	550	cosmicV97nov2022
EGFR_ENST00000454757	No	Afatinib	T745M	T	745	M	2234C>T	C	T	lung	carcinoma	bronchioloalveolar_adenocarcinoma	NS	Unknown	ENST00000454757.6	745	P00533	790	cosmicV97nov2022
KIT	Yes	Imatinib	T670I	T	670	I	2009C>T	C	T	soft_tissue	gastrointestinal_stromal_tumour	spindle_and_epithelioid	NS	Unknown	ENST00000288135.5	670	P10721	670	cosmicV97nov2022
FGFR2_ENST00000358487	No	BGJ398	N549K	N	549	K	?	?	NA	biliary_tract	carcinoma	adenocarcinoma	NS	Unknown	ENST00000358487.9	549	P21802	549	cosmicV97nov2022
EGFR_ENST00000455089	No	Osimertinib	L747P	L	747	P	2240T>C	T	C	lung	carcinoma	adenocarcinoma	NS	Unknown	ENST00000455089.5	747	P00533	792	cosmicV97nov2022
ABL1	Yes	Tyrosine kinase inhibitor - NS	T334I	T	334	I	1001C>T	C	T	haematopoietic_and_lymphoid_tissue	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	Unknown	ENST00000372348.6	334	P00519	315	cosmicV97nov2022
ALK_ENST00000642122	No	Alectinib	I103N	I	103	N	308T>A	T	A	lung	carcinoma	adenocarcinoma	NS	Heterozygous	ENST00000642122.1	103	Q9UM73	1171	cosmicV97nov2022
MET	Yes	Crizotinib	D1246H	D	1246	H	?	?	NA	lung	carcinoma	adenocarcinoma	NS	Unknown	ENST00000318493.10	1246	P08581	1228	cosmicV97nov2022
PDGFRA	Yes	Sunitinib	D842V	D	842	V	2525A>T	A	T	soft_tissue	gastrointestinal_stromal_tumour	epithelioid	NS	Heterozygous	ENST00000257290.9	842	P16234	842	cosmicV97nov2022
FGFR2_ENST00000358487	No	Debio1347	M537I	M	537	I	?	?	NA	biliary_tract	carcinoma	adenocarcinoma	NS	Unknown	ENST00000358487.9	537	P21802	537	cosmicV97nov2022
FGFR2_ENST00000357555	No	BGJ398	L528M	L	528	M	1582T>A	T	A	biliary_tract	carcinoma	adenocarcinoma	NS	Unknown	ENST00000357555.9	528	P21802	617	cosmicV97nov2022
EGFR	Yes	Erlotinib	T790M	T	790	M	2369C>T	C	T	lung	carcinoma	non_small_cell_carcinoma	NS	Unknown	ENST00000275493.6	790	P00533	790	cosmicV97nov2022
KIT	Yes	Imatinib	D816G	D	816	G	2447A>G	A	G	soft_tissue	gastrointestinal_stromal_tumour	spindle	NS	Heterozygous	ENST00000288135.5	816	P10721	816	cosmicV97nov2022
FGFR2_ENST00000478859	No	INCB054828	N321H	N	321	H	961A>C	A	C	biliary_tract	carcinoma	adenocarcinoma	NS	Unknown	ENST00000478859.5	321	P21802	549	cosmicV97nov2022
EGFR_ENST00000455089	No	Gefitinib	T745M	T	745	M	2234C>T	C	T	lung	carcinoma	squamous_cell_carcinoma	NS	Unknown	ENST00000455089.5	745	P00533	790	cosmicV97nov2022
KIT	Yes	Imatinib	V654A	V	654	A	1961T>C	T	C	soft_tissue	gastrointestinal_stromal_tumour	spindle_and_epithelioid	NS	Unknown	ENST00000288135.5	654	P10721	654	cosmicV97nov2022
EGFR	Yes	Tyrosine kinase inhibitor - NS	T790M	T	790	M	?	?	NA	lung	carcinoma	micropapillary_adenocarcinoma	NS	Unknown	ENST00000275493.6	790	P00533	790	cosmicV97nov2022
KIT	Yes	Imatinib	V654A	V	654	A	1961T>C	T	C	soft_tissue	gastrointestinal_stromal_tumour	spindle	NS	Homozygous	ENST00000288135.5	654	P10721	654	cosmicV97nov2022
KIT	Yes	Imatinib	D820Y	D	820	Y	2458G>T	G	T	soft_tissue	gastrointestinal_stromal_tumour	spindle	NS	Heterozygous	ENST00000288135.5	820	P10721	820	cosmicV97nov2022
ABL1_ENST00000318560	No	Tyrosine kinase inhibitor - NS	T315I	T	315	I	?	?	NA	haematopoietic_and_lymphoid_tissue	haematopoietic_neoplasm	blast_phase_chronic_myeloid_leukaemia	NS	Unknown	ENST00000318560.5	315	P00519	315	cosmicV97nov2022
BTK_ENST00000308731	No	Ibrutinib	C481S	C	481	S	1442G>C	G	C	haematopoietic_and_lymphoid_tissue	lymphoid_neoplasm	chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma	NS	Heterozygous	ENST00000308731.7	481	Q06187	481	cosmicV97nov2022
EGFR_ENST00000455089	No	Osimertinib	L747R	L	747	R	2240T>G	T	G	lung	carcinoma	adenocarcinoma	NS	Unknown	ENST00000455089.5	747	P00533	792	cosmicV97nov2022
EGFR	Yes	Gefitinib	T790M	T	790	M	?	?	NA	lung	carcinoma	pleomorphic_carcinoma	NS	Unknown	ENST00000275493.6	790	P00533	790	cosmicV97nov2022
EGFR	Yes	Osimertinib	C797S	C	797	S	2390G>C	G	C	lung	carcinoma	small_cell_carcinoma	NS	Unknown	ENST00000275493.6	797	P00533	797	cosmicV97nov2022
EGFR	Yes	Osimertinib	L792R	L	792	R	2375T>G	T	G	lung	carcinoma	adenocarcinoma	NS	Unknown	ENST00000275493.6	792	P00533	792	cosmicV97nov2022
EGFR	Yes	Osimertinib	L792V	L	792	V	2374C>G	C	G	lung	carcinoma	adenocarcinoma	NS	Unknown	ENST00000275493.6	792	P00533	792	cosmicV97nov2022
FGFR2_ENST00000369059	No	INCB054828	N435H	N	435	H	1303A>C	A	C	biliary_tract	carcinoma	adenocarcinoma	NS	Unknown	ENST00000369059.5	435	P21802	549	cosmicV97nov2022
ALK	Yes	Ceritinib	L1196M	L	1196	M	?	?	NA	lung	carcinoma	non_small_cell_carcinoma	NS	Unknown	ENST00000389048.7	1196	Q9UM73	1196	cosmicV97nov2022
ABL1_ENST00000318560	No	Dasatinib	G250E	G	250	E	?	?	NA	haematopoietic_and_lymphoid_tissue	haematopoietic_neoplasm	blast_phase_chronic_myeloid_leukaemia	NS	Unknown	ENST00000318560.5	250	P00519	250	cosmicV97nov2022
BTK_ENST00000618050	No	Ibrutinib	C481S	C	481	S	1442G>C	G	C	haematopoietic_and_lymphoid_tissue	lymphoid_neoplasm	chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma	NS	Heterozygous	ENST00000618050.4	481	Q06187	481	cosmicV97nov2022
EGFR	Yes	Osimertinib	T790M	T	790	M	?	?	NA	lung	carcinoma	adenocarcinoma	NS	Unknown	ENST00000275493.6	790	P00533	790	cosmicV97nov2022
ABL1	Yes	Imatinib	T334I	T	334	I	1001C>T	C	T	haematopoietic_and_lymphoid_tissue	lymphoid_neoplasm	acute_lymphoblastic_leukaemia	Ph_positive	Heterozygous	ENST00000372348.6	334	P00519	315	cosmicV97nov2022
PDGFRA	Yes	Imatinib	D842V	D	842	V	2525A>T	A	T	soft_tissue	gastrointestinal_stromal_tumour	epithelioid	NS	Heterozygous	ENST00000257290.9	842	P16234	842	cosmicV97nov2022
ABL1	Yes	Imatinib	T334I	T	334	I	1001C>T	C	T	haematopoietic_and_lymphoid_tissue	haematopoietic_neoplasm	chronic_myeloid_leukaemia	Ph_positive	Heterozygous	ENST00000372348.6	334	P00519	315	cosmicV97nov2022
FGFR4	Yes	Fisogatinib	V550L	V	550	L	1648G>C	G	C	liver	carcinoma	hepatocellular_carcinoma	NS	Unknown	ENST00000292408.8	550	P22455	550	cosmicV97nov2022
ALK_ENST00000618119	No	Lorlatinib	G825R	G	825	R	2473G>A	G	A	lung	carcinoma	adenocarcinoma	NS	Unknown	ENST00000618119.4	825	Q9UM73	1202	cosmicV97nov2022
MET	Yes	Crizotinib	D1246N	D	1246	N	3736G>A	G	A	breast	carcinoma	basal_(triple-negative)_carcinoma	NS	Unknown	ENST00000318493.10	1246	P08581	1228	cosmicV97nov2022
ABL1	Yes	Tyrosine kinase inhibitor - NS	D295G	D	295	G	884A>G	A	G	haematopoietic_and_lymphoid_tissue	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	Unknown	ENST00000372348.6	295	P00519	276	cosmicV97nov2022
KIT	Yes	Imatinib	K642E	K	642	E	1924A>G	A	G	soft_tissue	gastrointestinal_stromal_tumour	NS	NS	Unknown	ENST00000288135.5	642	P10721	642	cosmicV97nov2022
EGFR	Yes	Osimertinib	C797S	C	797	S	2389T>A	T	A	lung	carcinoma	non_small_cell_carcinoma	NS	Heterozygous	ENST00000275493.6	797	P00533	797	cosmicV97nov2022
FGFR2	Yes	Palbociclib	N550K	N	550	K	1650T>A	T	A	breast	carcinoma	ER-positive_carcinoma	NS	Unknown	ENST00000457416.6	550	P21802	549	cosmicV97nov2022
BTK	Yes	Ibrutinib	C515R	C	515	R	1543T>C	T	C	haematopoietic_and_lymphoid_tissue	lymphoid_neoplasm	chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma	NS	Homozygous	ENST00000621635.4	515	Q06187	481	cosmicV97nov2022
EGFR	Yes	Osimertinib	C797G	C	797	G	?	?	NA	lung	carcinoma	adenocarcinoma	NS	Unknown	ENST00000275493.6	797	P00533	797	cosmicV97nov2022
EGFR	Yes	Osimertinib	L792P	L	792	P	2375T>C	T	C	lung	carcinoma	adenocarcinoma	NS	Unknown	ENST00000275493.6	792	P00533	792	cosmicV97nov2022
FGFR1_ENST00000447712	No	Palbociclib	N546K	N	546	K	1638C>A	C	A	breast	carcinoma	ER-positive_carcinoma	NS	Unknown	ENST00000447712.6	546	P11362	546	cosmicV97nov2022
FGFR2_ENST00000357555	No	Palbociclib	N460K	N	460	K	1380T>A	T	A	breast	carcinoma	ER-positive_carcinoma	NS	Unknown	ENST00000357555.9	460	P21802	549	cosmicV97nov2022
FGFR2_ENST00000369059	No	Palbociclib	N435K	N	435	K	1305T>A	T	A	breast	carcinoma	ER-positive_carcinoma	NS	Unknown	ENST00000369059.5	435	P21802	549	cosmicV97nov2022
KIT	Yes	Imatinib	N822K	N	822	K	2466T>A	T	A	soft_tissue	gastrointestinal_stromal_tumour	NS	NS	Unknown	ENST00000288135.5	822	P10721	822	cosmicV97nov2022
ALK_ENST00000618119	No	Crizotinib	F797L	F	797	L	2391C>G	C	G	soft_tissue	inflammatory_myofibroblastic_tumour	NS	NS	Homozygous	ENST00000618119.4	797	Q9UM73	1174	cosmicV97nov2022
ALK	Yes	Alectinib	I1171N	I	1171	N	3512T>A	T	A	lung	carcinoma	adenocarcinoma	NS	Heterozygous	ENST00000389048.7	1171	Q9UM73	1171	cosmicV97nov2022
ALK_ENST00000618119	No	Alectinib	I794N	I	794	N	2381T>A	T	A	lung	carcinoma	adenocarcinoma	NS	Heterozygous	ENST00000618119.4	794	Q9UM73	1171	cosmicV97nov2022
MAP2K2	Yes	Dabrafenib	C125S	C	125	S	374G>C	G	C	skin	malignant_melanoma	NS	NS	Heterozygous	ENST00000262948.9	125	P36507	125	cosmicV97nov2022
ALK_ENST00000618119	No	Crizotinib	C779Y	C	779	Y	2336G>A	G	A	lung	carcinoma	adenocarcinoma	NS	Heterozygous	ENST00000618119.4	779	Q9UM73	1156	cosmicV97nov2022
FGFR1_ENST00000532791	No	Palbociclib	N544K	N	544	K	1632C>A	C	A	breast	carcinoma	ER-positive_carcinoma	NS	Unknown	ENST00000532791.5	544	P11362	546	cosmicV97nov2022
FLT3	Yes	Quizartinib	D835I	D	835	I	?	?	NA	haematopoietic_and_lymphoid_tissue	haematopoietic_neoplasm	acute_myeloid_leukaemia	NS	Unknown	ENST00000241453.11	835	P36888	835	cosmicV97nov2022
FGFR2_ENST00000358487	No	Debio1347	N549H	N	549	H	?	?	NA	biliary_tract	carcinoma	adenocarcinoma	NS	Unknown	ENST00000358487.9	549	P21802	549	cosmicV97nov2022
FGFR2_ENST00000358487	No	BGJ398	L617M	L	617	M	1849T>A	T	A	biliary_tract	carcinoma	adenocarcinoma	NS	Unknown	ENST00000358487.9	617	P21802	617	cosmicV97nov2022
MAP2K2	Yes	Dabrafenib	E207K	E	207	K	619G>A	G	A	skin	malignant_melanoma	NS	NS	Heterozygous	ENST00000262948.9	207	P36507	207	cosmicV97nov2022
ALK	Yes	Alectinib	G1202R	G	1202	R	3604G>A	G	A	lung	carcinoma	non_small_cell_carcinoma	NS	Unknown	ENST00000389048.7	1202	Q9UM73	1202	cosmicV97nov2022
KIT	Yes	Crizotinib	D816G	D	816	G	2447A>G	A	G	lung	carcinoma	adenocarcinoma	NS	Heterozygous	ENST00000288135.5	816	P10721	816	cosmicV97nov2022
FGFR2_ENST00000369056	No	Palbociclib	N550K	N	550	K	1650T>A	T	A	breast	carcinoma	ER-positive_carcinoma	NS	Unknown	ENST00000369056.5	550	P21802	549	cosmicV97nov2022
FGFR2_ENST00000351936	No	INCB054828	N549H	N	549	H	1645A>C	A	C	biliary_tract	carcinoma	adenocarcinoma	NS	Unknown	ENST00000351936.10	549	P21802	549	cosmicV97nov2022
MET	Yes	Crizotinib	Y1248C	Y	1248	C	3743A>G	A	G	lung	carcinoma	adenocarcinoma	NS	Unknown	ENST00000318493.10	1248	P08581	1230	cosmicV97nov2022
BTK_ENST00000618050	No	Ibrutinib	C481Y	C	481	Y	1442G>A	G	A	haematopoietic_and_lymphoid_tissue	lymphoid_neoplasm	lymphoplasmacytic_lymphoma	NS	Unknown	ENST00000618050.4	481	Q06187	481	cosmicV97nov2022
BTK_ENST00000308731	No	Ibrutinib	C481R	C	481	R	1441T>C	T	C	haematopoietic_and_lymphoid_tissue	lymphoid_neoplasm	chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma	NS	Homozygous	ENST00000308731.7	481	Q06187	481	cosmicV97nov2022
FGFR1_ENST00000356207	No	Palbociclib	N457K	N	457	K	1371C>A	C	A	breast	carcinoma	ER-positive_carcinoma	NS	Unknown	ENST00000356207.9	457	P11362	546	cosmicV97nov2022
FGFR2_ENST00000358487	No	FGFR	M538L	M	538	L	?	?	NA	biliary_tract	carcinoma	adenocarcinoma	NS	Unknown	ENST00000358487.9	538	P21802	538	cosmicV97nov2022
EGFR_ENST00000455089	No	Gefitinib	T745M	T	745	M	2234C>T	C	T	lung	carcinoma	bronchioloalveolar_adenocarcinoma	NS	Unknown	ENST00000455089.5	745	P00533	790	cosmicV97nov2022
MAP2K1	Yes	Selumetinib	P124L	P	124	L	371C>T	C	T	skin	malignant_melanoma	NS	NS	Heterozygous	ENST00000307102.9	124	Q02750	124	cosmicV97nov2022
EGFR	Yes	HM61713	C797S	C	797	S	2390G>C	G	C	lung	carcinoma	adenocarcinoma	NS	Unknown	ENST00000275493.6	797	P00533	797	cosmicV97nov2022
EGFR_ENST00000455089	No	HM61713	C752S	C	752	S	2255G>C	G	C	lung	carcinoma	adenocarcinoma	NS	Unknown	ENST00000455089.5	752	P00533	797	cosmicV97nov2022
BTK_ENST00000618050	No	Ibrutinib	C481R	C	481	R	1441T>C	T	C	haematopoietic_and_lymphoid_tissue	lymphoid_neoplasm	chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma	NS	Homozygous	ENST00000618050.4	481	Q06187	481	cosmicV97nov2022
FLT3	Yes	Crenolanib	D835I	D	835	I	?	?	NA	haematopoietic_and_lymphoid_tissue	haematopoietic_neoplasm	acute_myeloid_leukaemia	NS	Unknown	ENST00000241453.11	835	P36888	835	cosmicV97nov2022
BTK_ENST00000618050	No	Ibrutinib	C481S	C	481	S	1442G>C	G	C	haematopoietic_and_lymphoid_tissue	lymphoid_neoplasm	chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma	Richter_transformation	Unknown	ENST00000618050.4	481	Q06187	481	cosmicV97nov2022
EGFR	Yes	Osimertinib	L792H	L	792	H	2375T>A	T	A	lung	carcinoma	non_small_cell_carcinoma	NS	Heterozygous	ENST00000275493.6	792	P00533	792	cosmicV97nov2022
FGFR2_ENST00000358487	No	FGFR	N549K	N	549	K	?	?	NA	biliary_tract	carcinoma	adenocarcinoma	NS	Unknown	ENST00000358487.9	549	P21802	549	cosmicV97nov2022
KIT	Yes	Sunitinib	N822K	N	822	K	2466T>A	T	A	soft_tissue	gastrointestinal_stromal_tumour	NS	NS	Heterozygous	ENST00000288135.5	822	P10721	822	cosmicV97nov2022
FGFR4_ENST00000502906	No	Fisogatinib	V550M	V	550	M	1648G>A	G	A	liver	carcinoma	hepatocellular_carcinoma	NS	Unknown	ENST00000502906.5	550	P22455	550	cosmicV97nov2022
KIT	Yes	Imatinib	V654A	V	654	A	?	?	NA	soft_tissue	gastrointestinal_stromal_tumour	dedifferentiated	anaplastic_and_spindle_and_epithelioid	Homozygous	ENST00000288135.5	654	P10721	654	cosmicV97nov2022
PDGFRA	Yes	Imatinib	D842V	D	842	V	2525A>T	A	T	soft_tissue	gastrointestinal_stromal_tumour	spindle	NS	Heterozygous	ENST00000257290.9	842	P16234	842	cosmicV97nov2022
FGFR2_ENST00000360144	No	INCB054828	N461H	N	461	H	1381A>C	A	C	biliary_tract	carcinoma	adenocarcinoma	NS	Unknown	ENST00000360144.7	461	P21802	549	cosmicV97nov2022
ABL1_ENST00000318560	No	Dasatinib	Y253H	Y	253	H	?	?	NA	haematopoietic_and_lymphoid_tissue	haematopoietic_neoplasm	chronic_myeloid_leukaemia	NS	Unknown	ENST00000318560.5	253	P00519	253	cosmicV97nov2022
EGFR	Yes	Gefitinib	T790M	T	790	M	?	?	NA	lung	carcinoma	micropapillary_adenocarcinoma	NS	Unknown	ENST00000275493.6	790	P00533	790	cosmicV97nov2022
ABL1_ENST00000318560	No	Dasatinib	E255K	E	255	K	?	?	NA	haematopoietic_and_lymphoid_tissue	lymphoid_neoplasm	acute_lymphoblastic_leukaemia	Ph_positive	Unknown	ENST00000318560.5	255	P00519	255	cosmicV97nov2022
FGFR2_ENST00000358487	No	Pemigatinib	N549H	N	549	H	?	?	NA	biliary_tract	carcinoma	adenocarcinoma	NS	Unknown	ENST00000358487.9	549	P21802	549	cosmicV97nov2022
KIT	Yes	Imatinib	V654A	V	654	A	1961T>C	T	C	soft_tissue	gastrointestinal_stromal_tumour	spindle	NS	Heterozygous	ENST00000288135.5	654	P10721	654	cosmicV97nov2022
MET	Yes	Crizotinib	D1246N	D	1246	N	3736G>A	G	A	lung	carcinoma	squamous_cell_carcinoma	NS	Unknown	ENST00000318493.10	1246	P08581	1228	cosmicV97nov2022
MET	Yes	Capmatinib	D1246N	D	1246	N	3736G>A	G	A	lung	carcinoma	adenocarcinoma	NS	Unknown	ENST00000318493.10	1246	P08581	1228	cosmicV97nov2022
EGFR_ENST00000454757	No	Erlotinib	T745M	T	745	M	2234C>T	C	T	lung	carcinoma	non_small_cell_carcinoma	NS	Heterozygous	ENST00000454757.6	745	P00533	790	cosmicV97nov2022
FGFR2_ENST00000351936	No	Palbociclib	N549K	N	549	K	1647T>A	T	A	breast	carcinoma	ER-positive_carcinoma	NS	Unknown	ENST00000351936.10	549	P21802	549	cosmicV97nov2022
